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ABSTRACT
Appetite regulation has exclusively been examined during the follicular phase (FP) of the
menstrual cycle, and it remains unclear whether the greater levels of estradiol (E2) and
progesterone (P4) in the luteal phase (LP) affect this process. Thus, the purpose of this study was
to utilize vigorous-intensity continuous training (VICT) as a method to modulate plasma
concentrations of E2 and P4 and examine their associations with post-exercise alterations in
acylated ghrelin, peptide tyrosine-tyrosine3-36 (PYY3-36), active glucagon like peptide-1 (GLP-1),
subjective appetite perceptions, and energy intake across the menstrual cycle. Eleven women
completed 30 min of VICT (80% 𝑉̇ O2max) in both the FP and LP in a randomized order. E2, P4,
acylated ghrelin, PYY3-36, active GLP-1, and appetite perceptions were measured pre-,
immediately, 30, and 90 min post-exercise, and energy intake was recorded for a 3-day period
beginning the day prior to each experimental session. E2 concentrations increased immediately
post-exercise (P=0.041) with no differences in P4 (P=0.078). Acylated ghrelin was significantly
lower in the FP compared to the LP (P=0.029), and active GLP-1 was elevated at 30 min postexercise compared to 90 min post-exercise (P=0.016). There were no observable effects of
exercise or menstrual cycle phase on PYY3-36 (P=0.305), overall appetite (P=0.616), or free-living
energy intake (P=0.244). These findings suggest the typical post-exercise suppression of acylated
ghrelin may be blunted in the presence of elevated sex hormones in the LP, though sex hormones
do not appear to play a role in the anorexigenic hormone response to acute exercise. Future work
should focus on the reproducibility of our findings to further elucidate the influence of sex
hormones on appetite regulation across the menstrual cycle.
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CHAPTER 1:
LITERATURE REVIEW

2
Introduction
The prevalence of overweight and obesity in Canada has increased significantly over recent
decades, with 36.3% of Canadians adults reporting as overweight, and 26.8% reporting as obese
in 2018 (Statistics Canada, 2019). Sedentary lifestyles coupled with an excessive consumption of
calorie-dense foods are important contributors to the current obesity epidemic, highlighting the
preventable nature of this major public health concern. Ultimately, prevention of overweight and
obesity centers on maintaining the body in a state of energy balance, when energy intake and
energy expenditure are at equilibrium (Donnelly et al. 2005), resulting in a stable body mass over
time. Increases in fat mass occur when energy intake continuously exceeds energy expenditure,
whereas decreases in fat mass require a prolonged energy deficit, where energy expenditure
continuously exceeds energy intake (Hall et al. 2012). Maintaining an energy deficit can be
attained through increasing energy expenditure via exercise or spontaneous physical activity,
decreasing energy intake by modifying diet, or both. However, in a society where sugar-laden,
energy-dense convenience foods are readily available, maintaining energy balance through diet
alone is proven difficult and may not provide a viable long-term solution as weight re-gain
following dietary restriction has been demonstrated in more than 50% of individuals who
undertake this method (Donnelly et al. 2005). Furthermore, dietary restriction has been shown to
diminish resting metabolic rate and spontaneous physical activity, partially or entirely negating the
intended energy deficit for weight loss. Thus, modifying only one component of energy balance
appears to be inefficient for sustained weight management, and more effective interventions are
required.
Exercise offers an alternative mechanism to restriction of food intake alone. As a widelyaccepted method to improve cardiorespiratory capacity, the health-related benefits of exercise are
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strongly supported (Astorino et al. 2012; Burgomaster et al. 2008; Burgomaster et al. 2005; Garber
et al. 2011; Gibala et al. 2006; Gillen et al. 2014; Hazell et al. 2010; MacPherson et al. 2011;
Whyte et al. 2010). The role of exercise in energy balance is also established, as it is well known
that increasing energy expenditure with an acute bout of exercise can induce an energy deficit
(Donnelly and Smith 2005). Indeed, exercise is frequently recommended as a mechanism to
induce weight loss by many public health organizations (Brauer et al. 2015; Shephard et al. 2004).
However, the energy deficit created through exercise does not always translate to weight loss
(Donnelly et al. 2003). When performed at the recommended intensity and duration prescribed by
the Canadian Society for Exercise Physiology (CSEP; ³150 min/wk at a moderate intensity),
weight loss is often less than anticipated (Thorogood et al. 2011), and the clinical effectiveness of
exercise as a weight loss strategy has been questioned (Doucet et al. 2011; Foright et al. 2018;
Thorogood et al. 2011).
Unfortunately, this finding is even more apparent in females, as though many exercise
interventions are effective for improving body composition in men, the same interventions are
often less effective in women (Anderson et al. 2007; Donnelly et al. 2003; Donnelly and Smith
2005; Hill et al. 1987; Potteiger et al. 2003; Sartorio et al. 2005; Westerterp et al. 1992). While
there are few studies that compare fat loss in men versus women, evidence for a sex difference
arises from studies demonstrating that men experience a greater magnitude of fat loss compared
to females, who either lose a lesser magnitude or maintain weight, despite engaging in the same
exercise protocol (Bagley et al. 2016; Ballor et al. 1991; Després et al. 1984; Donnelly et al. 2003;
Donnelly and Smith 2005; Westerterp et al. 1992). The most convincing evidence stems from the
first long-term, randomized, supervised, and sufficiently powered study (The Midwest Exercise
Trial) conducted to compare weight losses between sexes due to exercise alone over a 16-month
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period (Donnelly et al. 2003). Participants received identical exercise prescriptions based on
intensity, frequency, and duration, progressing from a workload of 55% to 70% of maximal oxygen
consumption (𝑉̇ O2max) for 20 to 45 minutes per session over the course of the study. Energy
expenditure was assessed every 4 months using doubly labeled water and resting metabolic rate
from indirect calorimetry in order to verify the minimum target of 400 kilocalories (kcal) per
session. Furthermore, all sessions were performed under the direct supervision of research
personnel to ensure the proper completion of prescribed exercise. The average energy expenditure
per session equated to ~667 kcal and ~438 kcal for men and women, respectively, resulting in a
mean difference of ~229 kcal per session, and after 16 months it was found that the women in the
group maintained their previous weight (+0.6 kg of body mass), demonstrating no significant
reductions in fat mass, whereas men lost ~5.2 kg of body mass, the majority of which (~96%)
resulting from a significant loss in fat mass (~4.9 kg). Taken together, these findings demonstrate
that while exercise can be used as an effective weight management tool in the absence of dietary
restriction, women respond less favourably to exercise in terms of fat loss when exercise is
prescribed as a relative intensity (Donnelly et al. 2003).
Others have argued that when energy expenditure is standardized at an absolute value for
men and women (ex., 500 kcal), the sexually divergent body composition response is eliminated
(Caudwell et al. 2013; Donnelly et al. 2013; Hagobian et al. 2013a; Schubert et al. 2013). This
finding was demonstrated most convincingly in a second randomized, controlled, sufficiently
powered and supervised study (The Midwest Exercise Trial 2) conducted by the same group,
assessing weight loss between sexes in response to exercise eliciting the same energy expenditure
(Donnelly et al. 2013; Donnelly et al. 2012). Participants were randomly assigned to expend either
400 or 600 kcal per session, 5 d/wk over a 10-month period, or to a no-exercise control group. The

5
same mechanisms were used to verify exercise completion as described above.

Results

demonstrated no significant differences in weight loss between men and women performing
exercise equating to either 400 or 600 kcal per session, and it was concluded that exercise
prescription using energy expenditure rather than intensity, frequency, and duration results in
similar weight loss across the sexes (Donnelly et al. 2013). However, it should be noted that to
achieve the same energy expenditure in an exercise session, women are required to work for
significantly longer periods of time at the same intensity (Caudwell et al. 2013; Donnelly et al.
2013). In the above case, women required ~48 min to expend 400 kcal, whereas men required ~31
min, equating to a 17 min difference between the groups that accounted for 35% of the total session
for women. Similarly, women required ~63 min/session to expend 600 kcal, compared to males
who required ~42 min/session, resulting in a 21-min difference, accounting for 33% of the total
session for women (Donnelly et al. 2013). These stark differences in the work requirement for
males and females to achieve a similar level of fat loss suggest the existence of a sex difference,
rather than demonstrate a lack thereof, as many researchers have purported. If men exercising for
the same duration at the same relative intensity as women demonstrate a greater magnitude of fat
loss, it is highly plausible to suggest that there may be an underlying factor affecting energy
balance in females, whereby the exercise-induced energy deficit is partially or fully negated. The
lower levels of fat loss in women exercising at the same relative intensity as men in combination
with the discrepant work necessary to achieve an absolute level of energy expenditure, and thus
similar fat losses, provide a strong argument for such an adaptive mechanism, and may underlie
the demonstrated differences between men and women.
In general, the difficulties experienced with weight loss accompanying exercise are
frequently attributed to adaptive mechanisms that some individuals recruit in response to exercise
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(Donnelly and Smith 2005). These compensatory behaviours, such a decrease in spontaneous
physical activity or an increase in energy intake (King et al. 2007), can oppose an energy deficit
induced by exercise, ultimately minimizing or altogether negating the negative energy balance
required for weight loss (King et al. 2012; Stubbs et al. 2004; Westerterp et al. 1992). Numerous
studies have documented no compensatory increase in energy intake immediately to 8 days
following an acute session of exercise in men (Hagobian et al. 2013b; King et al. 1997; Stubbs et
al. 2002a), or women during the follicular phase of the menstrual cycle (Hagobian et al. 2013b;
McLaughlin et al. 2006). However, partial compensation accounting for ~30% of the exerciseinduced energy deficit has been documented when energy intake is tracked for a period of two
weeks (Stubbs et al. 2004; Stubbs et al. 2002b; Westerterp et al. 1992; Whybrow et al. 2008).
While this partial compensation response has been identified in both sexes, it has been suggested
that women demonstrate greater adaptive responses as a mechanism to preserve reproductive
functions, and more accurately match energy intake with energy expenditure to defend against
weight loss (Hagobian et al. 2009; Wade et al. 2004). As such, it is possible that these differences
in compensatory responses to exercise may partially explain the greater fat losses seen in men
versus women.
In line with the notion that females may exhibit more potent compensatory responses to
energy deficits in order to preserve reproductive function, it is plausible that the reduced efficacy
of exercise for weight loss in females may be related to 17b-Estradiol (E2) and progesterone (P4),
two of the main ovarian sex hormones involved in the menstrual cycle. These hormones are known
to influence energy intake over the course of the cycle such that the fluctuations in energy intake
coincide with fluctuations in sex hormones, suggesting a potential role in compensatory eating
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(Dye et al. 1997; Johnson et al. 1994; Shi et al. 2009; Sinchak et al. 2012). However, before these
changes are discussed, the physiology of a typical menstrual cycle will be briefly reviewed.

The Menstrual Cycle
Basic Physiology
In humans, ovulation occurs in spontaneous cycles that occur regularly from puberty to
menopause and is known as the menstrual cycle. The menstrual cycle is under control of the
hypothalamic-pituitary-gonadal axis (HPG axis), and involves a complex interaction between
several hormones, including the hypothalamic neurohormone gonadotropin-releasing hormone
(GnRH), pituitary hormones luteinizing hormone (LH) and follicle-stimulating hormone (FSH),
as well as the gonadal steroid hormones E2 and P4 (Asarian et al. 2013; Bonen et al. 1983). Various
forms of estrogen exist, but the most biologically active form in healthy young women is 17bEstradiol (E2) (Hirschberg 2012). GnRH is secreted from the hypothalamus, leading to subsequent
secretion of the gonadotropins, FSH and LH, from the anterior pituitary. These hormones, in
combination with E2 and P4, provide positive and negative feedback signals to the pituitary and
hypothalamus that lead to changing hormone secretion throughout the menstrual cycle (Reilly
2000). Based on the different hormonal profiles, the menstrual cycle can be divided into distinct
phases, including the follicular phase (FP), the ovulatory phase (OP), and the luteal phase (LP).
The FP begins with the onset of menses and is characterized by the development of the
immature follicle into a secondary, mature follicle containing a mature oocyte. Throughout the
FP, the developing follicle begins to release E2, triggering a sharp rise in the secretion of LH to
induce ovulation, or the release of the mature oocyte from the follicle. On average, ovulation
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occurs ~36 h after the LH surge, on day 14 of the menstrual cycle, and constitutes the OP (Asarian
and Geary 2013; Buffenstein et al. 1995). The cycle now enters the LP, in which the remaining
portion of the secondary follicle develops into the corpus luteum and produces large amounts of
P4. The LP is thus characterized by a P4-dominant state and terminates at the start of menses
(Frankovich et al. 2000). Of the sex hormones involved in the menstrual cycle, both E2 and P4
have been shown to have important implications in the regulation of appetite (Hirschberg 2012).

The Menstrual Cycle and Energy Balance
A close coupling between the fluctuations of ovarian sex hormones throughout the phases
of the menstrual cycle and energy intake has been well documented in both rats (Asarian and Geary
2002; Asarian and Geary 2006; Bartness and Waldbillig 1984;) and humans (Asarian et al. 2006;
Asarian and Geary 2013; Bisdee et al. 1989; Buffenstein et al. 1995; Dye and Blundell 1997;
Hirschberg 2012) (Figure 1). Specifically in humans, a plethora of studies demonstrate a decrease
in energy intake throughout the FP that reaches a minimum during the OP when E2 levels are
greatest (Asarian and Geary 2013; Bisdee et al. 1989; Buffenstein et al. 1995; Dye and Blundell
1997; Hirschberg 2012). Conversely, the greatest energy intake is observed in the LP when P4 is
at its greatest (Brennan et al. 2009; Bryant et al. 2006; Buffenstein et al. 1995; Cross et al. 2001;
Dye and Blundell 1997; Reed et al. 2008), with the average differences in energy intake between
the OP and LP equating to ~275 kcal/day, and between the mid-FP and mid-LP equating to ~228
kcal/day (Asarian and Geary, 2013). These findings are highly reproducible and are consistently
demonstrated despite considerable methodological variations between studies (Buffenstein et al.
1995). Interestingly, these cyclic fluctuations in eating do not occur during anovulatory cycles
(Buffenstein et al. 1995), evidence which – collectively with the similar cyclicity of eating in rats
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– suggest that eating behaviour is under the control of the HPG axis and influenced by ovarian
hormones in females (Asarian and Geary 2013).

Figure 1: Schematic changes in energy intake (top) and gonadal hormones (bottom) across an
average 28-day menstrual cycle. Energy intake is reduced in the periovulatory period when
plasma estradiol (E2) peaks, and energy intake increases in the luteal phase when plasma
progesterone (P4) is elevated [Adapted from Hirschberg 2012].
The effects of ovarian hormones on eating behaviour has been studied in detail with rodent
models and it is hypothesized that the reduced energy intake in the OP may be attributed to an
appetite-inhibiting, or anorexigenic effect of E2 (Sinchak and Wagner 2012; Wade 1972).
Ovariectomy of adult female rats (thus with a substantial decrease in circulating E2) demonstrate
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an immediate and sustained increase in energy intake, weight gain, and adiposity (Butera 2010;
Kakolewski et al. 1968; Wade 1972).

Reversal of these effects is observed when normal

physiological levels of E2 are restored (Asarian et al. 2002; Butera 2010; Wade 1972). Similarly,
when E2 is administered to the paraventricular nucleus of the hypothalamus (Butera et al. 1996) or
the ventromedial hypothalamus (Wade and Zucker 1970) of ovariectomized rats, a decrease in
energy intake is observed, whereas direct placement of E2 in brain regions not involved in the
control of feeding behaviour do not show this response (Butera et al. 1996).
The effects of P4 on eating behaviour are less clear, as it is always present with increasing
concentrations of E2, and no methods exist to isolate its effect across the menstrual cycle
(Stachenfeld et al. 2014). Despite this methodological shortcoming in humans, the impact of
ovariectomy and hormone therapy in rodent models suggests P4 does not have a direct orexigenic
effect, as treatment with P4 does not have a significant influence on energy intake unless
administered in abnormal, supra-physiological doses (Butera 2010). Thus, these findings suggest
P4 is not directly involved in altering feeding behaviour, and rather than exerting an orexigenic
effect, an anti-estrogenic effect appears to be more plausible (Frankovich and Lebrun 2000; Wade
1972). Certain metabolic actions of E2 are antagonized in the presence of P4 (Frankovich and
Lebrun 2000), and it is possible that the appetite-inhibitory effects of E2 are also antagonized
(Davidsen et al. 2007; Wade 1972). For example, when P4 levels were artificially elevated in
rhesus monkeys, E2 levels were decreased, and the E2 surge that precedes the LH surge did not
occur (Hess et al. 1973). Taken together, these findings suggest that the increase in energy intake
observed in the LP, characterized by its P4-dominated state, may be partially attributable to a
potentially anti-estrogenic effect of P4.
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It is important to discuss both components of energy balance (i.e., expenditure and intake)
to provide a more holistic understanding of the potential effects of the menstrual cycle on weight
management. If women are to maintain energy balance across the cycle, shifts in energy intake
should be met with shifts in energy expenditure of the same magnitude. As such, it has been
suggested that changes in resting metabolic rate (RMR) may mirror, or compensate for, the
demonstrated fluctuations in energy intake (Webb 1988), and that increases in total daily energy
expenditure may be due to cyclic changes in RMR, the largest portion of daily energy turnover.
Similar fluctuations in 24-h energy expenditure have been reported between phases, equating to
an increase of ~89-279 kcal/day, or 2.5-11% in the LP vs. the FP (Davidsen et al. 2007), though
are less consistent than the changes observed with energy intake (Buffenstein et al. 1995; Davidsen
et al. 2007). Data from the same group of women are required to directly investigate the hypothesis
of parallel changes between energy intake and RMR, and the only group to investigate this
relationship demonstrated changes of similar magnitude (Pelkman et al. 2001). It is unknown
whether the change in energy intake across the menstrual cycle is driven by the change in energy
expenditure, or vice versa.
In absence of corresponding increases in energy expenditure, the consistently greater
energy intake in the LP would lead to an energy imbalance and gradual increase in body mass over
time, as chronic overconsumptions as small as ~50-100 kcal over time can result in obesity
(Garland et al. 2011). A steady increase in body mass (primarily from an increase in fat mass) was
exhibited in the control group of women over a period of 16 months during the Midwest Exercise
Trial (Donnelly et al. 2003), whereas this weight gain was prevented in the group of exercising
women over the course of study. It is possible that women in the control group did not correct for
the energy intake imbalance between phases, as has been speculated to be the case for women with
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a greater tendency towards obesity (Buffenstein et al. 1995). However, this speculation should be
interpreted with caution, as a gradual increase in body mass was not observed over 10 months in
the Midwest Exercise Trial 2 control group of women (Donnelly et al. 2013). In the former
scenario, it is plausible to suggest that alterations in other components of energy balance (ex.
spontaneous physical activity, and as discussed above, RMR) may occur that mimic the
fluctuations in energy intake to maintain energy balance across the cycle. Such precise matching
between intake and expenditure between phases could potentially explain the lack of weight
change over time, and additionally may partially play a role in the sex differences in weight losses
following exercise. Further work is required to more clearly elucidate the relationship between
energy intake and energy expenditure across the menstrual cycle.
Despite the lack of consensus regarding the interplay between expenditure and intake
across the menstrual cycle, evidence of a consistent imbalance of energy intake between the FP
and LP remains strong, and is likely related to an anorexigenic, or appetite-inhibitory effect of E2.
The effects of E2 on energy intake are linked to E2 receptors in the hypothalamus, a key homeostatic
brain region involved in appetite regulation (Butera 2010; Hirschberg 2012). Within the arcuate
nucleus (ARC) of the hypothalamus exist two distinct neuronal populations: appetite-stimulating
neurons that secrete neuropeptide Y (NPY) and agouti-related peptide (AgRP), and appetiteinhibiting neurons that secrete pro-opiomelanocortin (POMC) and cocaine- and amphetaminerelated transcript (CART). Among these neurons are numerous E2 receptors, and as such it remains
possible that E2 exhibits its satiety-inducing effects via direct stimulation of these neurons (Butera
2010). Indeed, E2 has been shown to stimulate POMC/CART activity, and inhibit NPY/AgRP
activity in female rodents (Sotonyi et al. 2010). Taken together, the majority of evidence suggests
E2 as the primary link between the HPG axis and neural control of feeding (Asarian and Geary

13
2006; Asarian and Geary 2013; Davidsen 2007), implicating a strong inhibitory role on food
intake. Importantly, the cyclic changes in eating, both in normally cycling rodents and in
ovariectomized rats subject to E2 treatment, is expressed as spontaneous changes in meal size
rather than meal frequency (Asarian and Geary 2013). Though minimal, there is also evidence to
indicate that cyclic fluctuations in eating in women are expressed as changes in spontaneous meal
size rather than meal frequency (Brennan et al. 2009). This specificity provides valuable insight
to the potential mechanisms underlying this process, and in light of the link between sex hormones
and the neural control of feeding behaviour, it is conceivable that E2, and to a lesser extent P4, may
exert their effects on energy intake through interactions with appetite hormones that regulate eating
on a meal-to-meal basis.

Appetite Regulation
Overview
Human eating is a complex behaviour involving physiological, psychological, and
neurological domains (Harrold et al. 2012). Key brain regions involved in energy balance,
including the hypothalamus and brainstem, are central integrators of a network of endocrine
signals from gut-derived hormones as well as neural signals transmitted from mechanoreceptors
and chemoreceptors in the gut (Murphy et al. 2004). Both episodic (acute responses to food
consumption) and tonic factors (chronic inputs reflective of total adiposity and energy stores)
contribute to the control of feeding and together, these signals provide information to regulate
energy intake (Harrold et al. 2012).
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The specific hormones involved in altering perceptions of hunger and satiety are either
orexigenic/appetite-stimulating or anorexigenic/appetite-inhibiting (Murphy and Bloom 2004).
Peripheral signals converge on the brain and are integrated in the arcuate nucleus (ARC) of the
hypothalamus, where specific neuronal populations modulate neuropeptide release.

The

orexigenic neurons express NPY and AgRP to promote increases in appetite whereas anorexigenic
neurons express POMC and CART to promote decreases in appetite (Cone et al. 2001; Murphy
and Bloom 2004). At the present, there is only one known orexigenic gut-derived hormone
(ghrelin) though there are numerous anorexigenic hormones, including glucagon-like peptide 1
(GLP-1), peptide tyrosine-tyrosine (PYY), cholecystokinin (CKK), pancreatic polypeptide (PP),
and amylin. However, as only ghrelin, GLP-1 and PYY are consistently demonstrated to respond
to acute exercise and subsequently contribute to energy intake (Hazell et al. 2016; Schubert et al.
2014), only these hormones will be included in the scope of this review.

Gastrointestinal Hormones
Ghrelin – Ghrelin is a 28-amino acid peptide hormone released from specialized endocrine
cells in the stomach during periods of energy restriction. It is actively converted to acylated ghrelin
by the addition of an O-octanoyl group on serine 3 (an eight-carbon fatty acid) by the enzyme
ghrelin O-acyl transferase (GOAT) in the stomach and small intestine (Yang et al. 2008).
Although acylated ghrelin composes only ~10-20% of the total ghrelin (acylated and des-acylated),
it is believed to be the only form that is involved in appetite-stimulation, and its acylation is a
required step in order to exert its orexigenic effects (Ghigo et al. 2005). Once in its active
(acylated) form, ghrelin crosses the blood-brain barrier and stimulates the NPY/AgRP neurons in
the ARC region of the hypothalamus to increase appetite, and blocking NPY/AgRP signaling

15
diminishes this response (Kojima et al. 2005). Exogenous acylated ghrelin administration into the
cerebral ventricles potently stimulates food consumption in both rodents (Kojima and Kangawa
2005) and humans (Wren et al. 2001). Plasma acylated ghrelin concentrations reflect episodic
hunger signaling, with pre-prandial elevations rapidly diminished post-prandially in proportion to
energy intake (i.e. caloric load), indicating its important role in meal initiation and termination.
Glucagon-like Peptide-1 (GLP-1) – GLP-1 is synthesized from a precursor protein
(preproglucagon) and is secreted by L cells, a subpopulation of enteroendocrine cells located in
the greatest density in the distal small intestine and colon (Lu et al. 2018). Two equipotent forms
exist in circulation (GLP-17-37 and GLP-17-36), with GLP-17-36 representing the majority in
circulating plasma (Drucker 2006; Orskov et al. 1994). Following a meal, GLP-1 is released into
circulation and is rapidly degraded by dipeptidyl peptidase-4 (DPP-IV) to GLP-19-36. Reflective
of its anorexigenic properties, direct administration of GLP-1 into rodent cerebrospinal fluid
reduces energy intake (Tang-Christensen et al. 1996), and exogenous intravenous administration
of GLP-1 inhibits energy intake in both lean and obese humans (Flint et al. 1998; Gutzwiller et al.
1999a; Gutzwiller et al. 1999b; Verdich et al. 2001).
Peptide YY (PYY) – PYY is co-secreted with GLP-1 from enteroendocrine L cells located
in the small and large intestine and has two active forms: PYY1-3 and PYY3-36. Similar to GLP-1,
PYY1-36 is proteolyzed by the DPP-IV enzyme to PYY3-36, which exerts more potent anorexigenic
effects (Cummings et al. 2007) and is found in the greatest concentrations in circulation (Batterham
et al. 2006). Reflective of its properties as an episodic, appetite-inhibiting signal, PYY3-36
concentrations are elevated immediately following energy intake, and administration of PYY3-36
inhibits energy intake in both rodents and humans (Batterham et al. 2003; Batterham et al. 2002).
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Exercise Intensity and Appetite Regulating Hormones
Given the rising obesity epidemic and prescription of exercise for weight loss, there is a
widespread interest in the effects of exercise on endocrine signals that ultimately impact energy
balance. Acute exercise of varying protocols (Table 1) has demonstrated effects on plasma
concentrations of appetite-regulating hormones, particularly acylated ghrelin, PYY, and GLP-1.
Table 1. Exercise characteristics (Gibala et al. 2006; Weston et al. 2014)
Type of training
Protocol
Moderate-intensity continuous training 30-90 min; ~50-70% 𝑉̇ O2max
(MICT)
High-intensity interval training
Repeated bouts of near maximal effort (i.e. ~80(HIIT)
100% % 𝑉̇ O2max) separated with low activity or rest
Sprint interval training
Potent form of interval training, traditionally
(SIT)
involving four to six repeated, 30-s supramaximal
(i.e. >100% 𝑉̇ O2max) sprints separated with 4 min of
rest or active recovery
Generally, research suggests that concentrations of acylated ghrelin, the only known
orexigenic hormone, decrease after a bout of exercise while concentrations of the anorexigenic
hormones PYY and GLP-1 increase (King et al. 2010a; Larson-Meyer et al. 2012; Schubert et al.
2014; Ueda et al. 2009a). Furthermore, some of these effects appear to occur in an intensitydependent manner (Hazell et al. 2016; Islam et al. 2017). Much of the research examining the
influence of acute exercise on appetite-regulating hormones has been conducted using moderateintensity continuous training (MICT) protocols, however, more recent research has examined the
impact of perturbations of greater intensity, including vigorous-intensity continuous training
(VICT), high-intensity interval training (HIIT), and sprint interval training (SIT).
Ghrelin – Numerous studies have examined the impact of acute MICT on plasma acylated
ghrelin concentrations and do not demonstrate consistent exercise effects. Some studies have
shown suppressions ranging from 14-60% compared to pre-exercise or resting levels (Balaguera-
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Cortes et al. 2011; Broom et al. 2009; Broom et al. 2017; Broom et al. 2007; Deighton et al. 2013a;
Kawano et al. 2013; King et al. 2015; King et al. 2010a; King et al. 2011b; Martins et al. 2015;
Marzullo et al. 2008; Shiiya et al. 2011; Tiryaki-Sonmez et al. 2013; Vatansever-Ozen et al. 2011;
Wasse et al. 2013), others have not (Hagobian et al. 2013b; Islam et al. 2017; King et al. 2010b;
King et al. 2011a; Larson-Meyer et al. 2012; Metcalfe et al. 2015; Sim et al. 2014), but a recent
meta-analysis demonstrates an overall 16.5% suppression of acylated ghrelin following MICT
(Schubert et al. 2014). In those studies where a reduction in plasma acylated ghrelin was observed,
the greatest effects were seen with more strenuous protocols that used slightly higher intensities
and longer durations of MICT (Broom et al. 2009; Deighton et al. 2013a; Islam et al. 2017; Shiiya
et al. 2011). As such, an important role for exercise intensity has been hypothesized, whereby the
suppressive effects are more pronounced following exercise of higher intensity (Hazell et al. 2016).
Indeed, recent research using near-maximal and supramaximal intensities have elicited a more
consistent decrease in plasma acylated ghrelin concentrations.

Immediate and prolonged

suppression occurred following a running bout of VICT (30 min at ~85% 𝑉̇ O2max), and SIT (4 "allout" efforts), while MICT (30 min at ~65% 𝑉̇ O2max) was not different than control (Islam et al.
2017). Others have also reported acylated ghrelin suppressions following both HIIT (Martins et
al. 2015) and various SIT protocols (Deighton et al. 2013a; Islam et al. 2017; Martins et al. 2015;
Panissa et al. 2016; Sim et al. 2014). Notably, supramaximal exercise has elicited significantly
greater and more prolonged suppressions than both MICT (Metcalfe et al. 2015; Sim et al. 2014)
and VICT (Islam et al. 2017), supporting an overall intensity-dependent acylated ghrelin reduction
in response to acute exercise.
GLP-1 – Much less research exists examining the effects of acute exercise on plasma GLP1 concentrations, with majority using MICT as the primary stimulus. Compared to rest, increases
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ranging from 11-50% (Islam et al. 2017; Ueda et al. 2009a; Ueda et al. 2009b) and 16-1477%
(Hallworth et al. 2017; Hazell et al. 2017a; Larson-Meyer et al. 2012; Martins et al. 2007; Martins
et al. 2015) have been observed in the concentrations of plasma active GLP-1 and total GLP-1,
respectively, following 30-60 min bouts of MICT at 50 – 75% 𝑉̇ O2max. A recent meta-analysis
revealed an overall increase of 13% following MICT (Schubert et al. 2014). Fewer studies have
examined GLP-1 responses to high-intensity exercise and have yielded conflicting results. Both
total (Hazell et al. 2017a; Martins et al. 2015) and active GLP-1 (Hazell et al. 2017a; Islam et al.
2017) are elevated following various SIT protocols, though another group reported no change in
active GLP-1 concentrations following traditional SIT (Beaulieu et al. 2015). It is possible that
total GLP-1 may respond differently than active GLP-1, however more work investigating the
discrepant responses is required. Taken together, it appears as though exercise intensity is less
closely associated with GLP-1 release, as evidenced by a similar release of active GLP-1 following
both MICT and VICT (Hazell et al. 2017a), and other factors such as reaching a threshold of energy
expenditure may be more important (Hazell et al. 2016). Further work is required to examine the
relationship between high-intensity protocols and GLP-1.
PYY – Several studies demonstrate increases in both total (Broom et al. 2009; Deighton et
al. 2013a; Hallworth et al. 2017; Hazell et al. 2017b; Islam et al. 2017; Kawano et al. 2013; Martins
et al. 2007; Ueda et al. 2009b) and active (Deighton et al. 2014; Deighton et al. 2013b; King et al.
2011a; Larson-Meyer et al. 2012; Russell et al. 2009) plasma PYY concentrations following 3060 min bouts of MICT at 50-70% 𝑉̇ O2max, with an overall 9% increase demonstrated in a metaanalysis (Schubert et al. 2014). As with acylated ghrelin, more strenuous MICT protocols
performed at higher intensities (≥ 70% 𝑉̇ O2max) appear to strengthen this response (Broom et al.
2009; King et al. 2011a; Larson-Meyer et al. 2012; Ueda et al. 2009a), which is in line with recent
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findings demonstrating a greater increase in PYY following VICT versus MICT (Islam et al.
2017). In contrast, no changes were found following several HIIT protocols (Martins et al. 2015;
Metcalfe et al. 2015; Sim et al. 2014) or a SIT protocol designed to induce a 250 kcal deficit, or a
short-duration SIT protocol inducing a 125 kcal deficit (Martins et al. 2015). Additionally, there
may be no difference between traditional SIT (Table 1) and MICT (Islam et al. 2017) though this
could be a result of a lower exercise volume (4 bouts of SIT) compared to previous protocols using
6 “all-out” bouts (Hazell et al. 2017a). Ultimately, these conflicting results prevent an unequivocal
conclusion to the effects of high-intensity intermittent exercise on PYY and suggest future research
should include PYY.

Appetite Perceptions and Energy Intake
Intimately linked with the fluctuations in appetite-regulatory hormones post-exercise are
changes in perceptions of appetite, the subjective measures of the motivation to eat (Gibbons et al.
2019). Appetite is measured via ratings of hunger, fullness, satisfaction, and prospective food
consumption, including a combined score of each component to calculate overall appetite, and is
typically assessed using a visual analogue scale (VAS; Gibbons et al. 2019). Appetite is influenced
by acute energy deficits created through exercise, and the interactions between exercise and the
appetite system have received considerable interest as a result of their direct implications for body
weight regulation. Often, the post-exercise decreases in acylated ghrelin and increases in GLP-1
and PYY occur simultaneously with a transient suppression of overall appetite (Deighton and
Stensel 2014; Dorling et al. 2018), and collectively contribute to an anorexigenic environment that
may influence the impact of exercise on energy balance. However, while some groups have
reported post-exercise reductions in free-living energy intake (Hagobian et al. 2013; Islam et al.
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2017; Sim et al. 2014), the majority of current evidence highlighted in a recent meta-analysis
demonstrates that single bouts of moderate- to high-intensity exercise do not alter free-living
energy intake immediately post-exercise (Schubert et al. 2014), suggesting that acute appetite
suppression does not necessarily translate into reduced energy intake. However, the results of the
meta-analysis did not suggest that individuals compensated for the exercise-induced energy deficit
with an increased energy intake post-exercise, thereby resulting in a decrease in relative energy
expenditure, and highlighting the important role that exercise plays in energy balance and longterm weight management.

Sex Differences in Appetite-Regulation
A major issue in the majority of the appetite regulation research is a primary focus on males
and far less research on females. This is likely due to difficulty in recruiting and collecting data
on females due to the menstrual cycle, as related hormonal fluctuations across the menstrual phases
are potential confounding factors. Thus, even when females are included as research subjects, they
are often studied in the early FP of the menstrual cycle when E2 and P4 concentrations are minimal
(Alajmi et al. 2016; Hagobian et al. 2009; Hagobian et al. 2013b; Hallworth et al. 2017; Hazell et
al. 2017b; Larson-Meyer et al. 2012; Panissa et al. 2016). However, evaluating appetite regulation
during a time that reflects only a portion of an adult female's life prevents a complete understanding
of appetite regulation in females. This is extremely problematic due to the previously described
issues with women and fat loss from exercise as it is plausible that exercise may affect appetite
regulating hormones differently in females than males, thereby altering post-exercise appetite
control and contributing to the apparent sex difference in intervention effectiveness. Thus,
evaluation of the sex-specific hormone response to exercise is necessary.
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In the limited studies that did distinguish between men and women, reports of a sex
difference are present, though equivocal (Alajmi et al. 2016; Hagobian et al. 2009; Hagobian et al.
2013b; Hazell et al. 2017b; Panissa et al. 2016). MICT (50-70% 𝑉̇ O2max) decreases acylated
ghrelin in males (Alajmi et al. 2016; Broom et al. 2009; Islam et al. 2017; King et al. 2010a;
Schubert et al. 2014) and females by ~22% (Alajmi et al. 2016; Howe et al. 2016), though acylated
ghrelin levels were significantly increased by ~25% (Hagobian et al. 2009) and 55% (LarsonMeyer et al. 2012) in women following a bout of cycling and running MICT (50-70% 𝑉̇ O2max),
respectively, while there were no differences in men (Hagobian et al. 2009). These findings
suggest that exercise alters acylated ghrelin to favour a post-exercise orexigenic environment in
women only. However, in more recent work directly comparing the appetite-regulatory response
in sexes, no differences in acylated ghrelin were found between men and women following running
or cycling MICT performed at 60-70% 𝑉̇ O2max (Alajmi et al. 2016; Hagobian et al. 2013b; Panissa
et al. 2016), SIT (60 x 8-s “all out” cycling sprints), or HIIT (1 min cycling repetitions at maximal
aerobic power) (Panissa et al.2016). Interestingly, one group reported no differences between
acylated ghrelin elevations following MICT and VICT in females, though both protocols
significantly suppressed acylated ghrelin immediately post-exercise by ~22% (Howe et al. 2016).
As with acylated ghrelin, there are inconsistent results regarding a sex difference in PYY
response. MICT (50-70% 𝑉̇ O2max) increases PYY in males (Broom et al. 2007; Deighton et al.
2013b; Hazell et al. 2017a; Islam et al. 2017) and females by ~9.5-25.0% (Hagobian et al. 2013b;
Hazell et al. 2017b; Howe et al. 2016; Larson-Meyer et al. 2012), though others reported no
significant elevation in PYY following MICT in females (Alajmi et al. 2016; Hallworth et al.
2017). Some suggest the increase may be greater in females than males (Hagobian et al. 2013b),
however others have demonstrated greater PYY in response to HIIT (60 x 8s sprints; (Panissa et
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al. 2016) and both MICT (30 min at 65% 𝑉̇ O2max) and SIT (6 x 30s "all out" sprints; (Hazell et al.
2017b) in males versus females. Furthermore, VICT significantly increased PYY in females
(~9.5%), however there was no difference between VICT and MICT (Howe et al. 2016), further
demonstrating the need for future research to uncover potential mechanisms involved in the effect
of exercise on appetite regulation.
Lastly, even less research exists examining a sex difference in GLP-1 where MICT (5070% 𝑉̇ O2max) increases total and active GLP-1 immediately post-exercise in males (Islam et al.
2017) and females by ~6.6-77% (Hallworth et al. 2017; Hazell et al. 2017b; Howe et al. 2016;
Larson-Meyer et al. 2012; Martins et al. 2007), however no change was observed following
walking MICT in females (Larson-Meyer et al. 2012). As with PYY, VICT significantly increased
GLP-1 in females (~77%), however no difference was observed between VICT and MICT (Howe
et al. 2016). Interestingly, in the only study to directly compare the GLP-1 response between men
and women, a clear sex difference was noted. GLP-1 was significantly elevated in women
immediately post MICT and SIT (6.6-8.2%), while no change was observed in men (Hazell et al.
2017b). This is in contrast to previous research demonstrating consistent post-exercise GLP-1
increases in men, however further work is necessary to comment on a sex difference in GLP-1
response to exercise.
Again, it is important to note that each study examining sex differences measured appetiteregulatory responses to exercise in the FP of the menstrual cycle, minimizing the effects of the
female sex hormones. At present, only three studies have examined appetite-regulatory hormones
during the LP of the menstrual cycle (Brennan et al. 2009; Campolier et al. 2016; McKie et al.
2018), and none have done so with exercise, which may present different findings than those
described above due to the characteristic fluctuations of E2 and P4 across the phases. Indeed, one
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group demonstrated that E2 and P4 fluctuations were associated with distinct hormonal responses
to feeding across the menstrual cycle at rest (McKie et al. 2018). The P4-dominant LP was
associated with greater fasting concentrations of acylated ghrelin, while E2 was strongly correlated
with fasting GLP-1 in the FP only. In addition, the post-prandial change in active PYY was lower
during the LP compared to the FP. In light of these differences, it is plausible that female sex
hormones may play a role in the appetite-regulatory response to exercise as they have been
suggested to be involved in energy intake changes across the cycle. Thus, it is important to study
females in other phases of the menstrual cycle, when a sex difference may be more likely to occur.

Sex Hormones and Exercise Intensity
At present, there exists minimal research exploring ovarian sex hormone responses to
exercise intensity. In the few studies that are available, it is evident that acute exercise of moderate
to vigorous-intensity is associated with increases in plasma concentrations of E2 and P4 similarly
across the phases of the menstrual cycle (Table 2).
Consistently, exercise performed at a low intensity (£40% 𝑉̇ O2max) does not significantly
increase plasma concentrations of E2 and P4 in either phase (Bonen et al. 1991; Jurkowski et al.
1978; Redman et al. 2003), though a single study has demonstrated a significant increase in P4
with exercise at ~40% 𝑉̇ O2max during the LP (Jurkowski et al. 1978). In the FP, elevations in E2
and P4 during exercise are not typically observed, unless exercise is performed at vigorous (8095% 𝑉̇ O2max) intensities (Bonen et al. 1991; Jurkowski et al. 1978), though moderate intensity
(~75% 𝑉̇ O2max) exercise has also been shown to increase P4 (Bonen et al. 1979). In the LP, both
E2 and P4 are significantly elevated during moderate (~65-75% 𝑉̇ O2max) and vigorous (~80-95%
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Table 2. Sex hormone response to exercise intensity
Paper
Intensity
%D [Absolute D]
FP
LP
E2
P4
E2
P4
Jurkowski et al. 1978
Light
6.26%
7.10%
9.32%
13.90%*
~40% VO2max
[23.86]
[0.12]
[68.29]
[4.01]
Moderate
15.22%
41.42%
36.59%*
38.94%*
~60% VO2max
[58.0]
[0.75]
[267.99]
[11.23]
Heavy
25.05%*
63.91%
35.39%*
37.83%*
~90% VO2max
[95.45]
[1.08]
[259.18]
[10.91]
Bonen et al. 1979#
Light
Moderate
-26.34%^
40.16%^*
15.60%*
21.61%*
~75% VO2max
[-50.66]
[0.51]
[152.35]
[1.56]
Heavy
#¨
Light
22.22%
18.75%
37.14%
6.89%
Bonen et al. 1991
~40% VO2max
[40.0]
[0.3]
[130.0]
[7.69]
Moderate
Heavy
38.89%*
112.50%*
80.0%*
48.28%*
~80% VO2max
[70.0]
[1.8]
[280.0]
[53.85]
Redman et al. 2003
Light
40.79%
8.0%
-1.39%
6.25%
~25% VO2max
[35.2]
[0.2]
[-5.1]
[1.4]
*
Moderate
84.24%
28.0%
31.24%
15.63%
~75% VO2max
[72.7]
[0.7]
[116.3]
[3.5]
Heavy
Note: All %D values were manually calculated.
%D = (post-exercise – pre-exercise)/pre-exercise x 100.
E2 = pmol·L-1; P4 = nmol·L-1; ^ = FP session occurred during menses. * = Significantly
different from resting values. # = Data extrapolated from figures.
¨
= Researchers did not distinguish significance between exercise intensities.
𝑉̇ O2max) exercise (Bonen et al. 1991; Jurkowski et al. 1978) suggesting a dose-response effect that
may affect P4 more than E2.
It is important to note that these elevations are observed during the exercise itself, as blood
samples were obtained in the final minutes of work performed at each of the relative intensities
(i.e. 40%, 80%, exhaustive exercise). Where post-exercise changes were sampled and reported,
findings are equivocal. An elevation of P4 in the FP persisted 30 min into the post-exercise period
in one study (Bonen et al. 1991), however others report a fall in plasma concentrations of both E2
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and P4 in the LP within this time frame (Bonen et al. 1991; Jurkowski et al. 1978). Additionally,
all studies that examined the influence of exercise intensity on these hormones utilized one session
per phase, whereby exercise at a low intensity was immediately followed by exercise at a higher
intensity. A limitation of this design is the lack of ability to distinguish between an intensity or
duration effect, as no study to date has examined the sex hormone response to intensity in separate
sessions consisting of either moderate or vigorous intensity alone. Thus, it is unknown whether
the significant elevations in E2 and P4 following MICT and VICT are due to the greater intensities
of the exercise, or due to the long durations (>40 min) of exercise. Further work in this area is
required to distinguish between these effects. An additional limitation is the timing of testing, as
this was inconsistent between studies, occurring at different times throughout the menstrual cycle.
The timing of testing may have important implications due to the characteristic fluctuations of
ovarian sex hormones across the menstrual cycle. Whereas hormones concentrations are low in
the FP, testing during the LP should occur mid-stage, as this is when P4 concentrations are
maximal.
Consequently, as a result of the demonstrated impact of exercise intensity on female sex
hormones, whereby no elevations tend to occur in the FP, and elevations occur in the LP in a doseresponse fashion, implementing a vigorous-intensity exercise protocol across the FP and LP may
offer a unique paradigm to study the effects of sex hormones on appetite regulation.

Summary
Aerobic exercise frequently results in a greater magnitude of fat loss in males but is less
effective in females. The difficulties females experience may be due fluctuations in sex hormones
throughout the menstrual cycle, particularly E2 and P4, as these hormones have been linked to
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differences in energy intake and may ultimately result in a compensatory response that negates the
exercise-induced energy expenditure. As energy intake is partially controlled through physiologic
mechanisms involving appetite-regulating hormones that are either orexigenic or anorexigenic,
examining whether E2 and P4 are involved in appetite-regulation is warranted. Few studies to date
have investigated females in this field of research, and all have done so exclusively in the FP of
the menstrual cycle. However, examining the effect of elevated E2 and P4 during the LP on
appetite-regulating hormones will offer new insights into potential mechanisms involved in
appetite regulation, and may lead to improved strategies for weight loss for women.

Purpose
Thus, the purpose of this study was to utilize VICT as a method to modulate plasma
concentrations of E2 and P4 and examine their associations with post-exercise alterations in
acylated ghrelin, PYY3-36, active GLP-1, subjective appetite perceptions, and free-living energy
intake during the follicular and luteal phases of the menstrual cycle.

Hypotheses
1. In the FP, E2 concentrations will be elevated in response to VICT, along with post-exercise
elevations in active GLP-1, PYY3-36 and decreases in acylated ghrelin, favouring a
suppression of overall appetite. No significant elevations in P4 will be observed in the FP.
2. In the LP, both E2 and P4 concentrations will be elevated in response to VICT, along with
post-exercise elevations in active GLP-1, PYY3-36 , and a suppression of acylated ghrelin.
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CHAPTER 2:
MANUSCRIPT
EXAMINING THE POTENTIAL INVOVLEMENT OF SEX HORMONES ON APPETITE
REGULATION IN FEMALES ACROSS THE MENSTRUAL CYCLE
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Introduction
In light of the current rates of overweight and obesity in Canada, an improved
understanding of the impact of exercise on energy balance is required. Generally, it is known that
increasing energy expenditure with an acute bout of aerobic exercise can induce an energy deficit
(Donnelly et al. 2005). However, this deficit does not consistently translate to weight loss
(Donnelly et al. 2003), and particularly not in females, who tend to exhibit lesser magnitudes of
fat loss compared to males despite engaging in identical exercise protocols (Bagley et al. 2016;
Ballor et al. 1991; Després et al. 1984; Donnelly et al. 2003; Donnelly and Smith 2005; Westerterp
et al. 1992), or who require significantly extended durations of exercise at the same relative
intensity to exhibit similar fat losses (Donnelly et al. 2013). The difficulties females experience
with weight loss accompanying exercise may be due to fluctuations in sex hormones throughout
the menstrual cycle, particularly estradiol (E2) and progesterone (P4), as these hormones have been
linked to fluctuations in energy intake between phases (Asarian et al. 2013).
The menstrual cycle is under the control of the hypothalamic-pituitary-gonadal (HPG) axis
and can be divided into three distinct phases, including the follicular phase (FP), the ovulatory
phase (OP), and the luteal phase (LP). The FP begins with the onset of menses and is characterized
by low levels of P4, and low but increasing levels of E2 that trigger a sharp rise in the secretion of
luteinizing hormone (LH) to induce ovulation (Asarian and Geary 2013). Occurring ~36 hours
following the LH surge on approximately day 14 of the cycle, ovulation constitutes the OP and
initiates the change to the LP, which is characterized by a P4-dominant state that terminates at the
start of menses (Asarian and Geary 2013; Frankovich et al. 2000). Convincing evidence from
studies in both animals (Czaja et al. 1975; Kemnitz et al. 1984) and humans (Brennan et al. 2009;
Bryant et al. 2006; Buffenstein et al. 1995; Cross et al. 2001; Fong et al. 1993; Gong et al. 1989;
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Johnson et al. 1994; Lissner et al. 1988; Lyons et al. 1989; Martini et al. 1994; Reed et al. 2008)
suggest a link between these fluctuations in E2 and P4 with the changes in energy intake.
Specifically, energy intake decreases throughout the FP to a minimum that coincides with the
greatest levels of E2 in the OP, and an increase in energy intake is observed in the LP when P4
reaches its peak concentration. On average, the differences in energy intake between the OP and
LP equate to ~275 kilocalories (kcal)/day, and that between the mid-follicular and mid-luteal
phases equates to ~228 kcal/day (Asarian and Geary 2013). Interestingly, these cyclic fluctuations
in energy intake are not present during anovulatory cycles (Barr et al. 1995; Rock et al. 1996).
Taken together, it is plausible to speculate that cyclic changes in energy intake across the menstrual
cycle are influenced by HPG axis function, suggesting the potential involvement of E2 and P4 in
appetite regulation (Asarian et al. 2006; Asarian and Geary 2013; Hirschberg 2012).
The physiological control of energy intake, known as appetite regulation, involves a
complex interplay between brain regions such as the hypothalamus and brainstem and the episodic
and tonic signalling of gut-derived peptides (Hussain et al. 2013). On a meal-to-meal basis, energy
intake is primarily mediated through episodic signalling, comprising of a number of peptides that
are released from the gastrointestinal tract. Such peptides are classified as being either orexigenic
(appetite-stimulating) or anorexigenic (appetite-inhibiting) in nature and influence our perceptions
of hunger before a meal and post-prandial satiety to regulate acute energy intake (Murphy et al.
2006). Acylated ghrelin, the only known orexigenic hormone, is a 28-amino acid peptide released
from specialized endocrine cells in the stomach that becomes biologically active (acylated) with
the addition of an octanoyl group by the ghrelin O-acyl transferase (GOAT) enzyme (Yang et al.
2008). Glucagon-like peptide 1 (GLP-1) and peptide tyrosine-tyrosine (PYY) are two of several
known anorexigenic hormones and are both released from enteroendocrine L cells in the small and
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large intestine (Murphy and Bloom 2006). These three peptides are notably perturbed by acute
exercise, whereby acylated ghrelin is typically suppressed (Schubert et al. 2014), potentially to a
greater extent following exercise of greater intensities (Islam et al. 2017), and is often accompanied
by simultaneous increases in GLP-1 and PYY (Hazell et al. 2016; Schubert et al. 2014). These
changes in appetite-regulatory hormones are accompanied by a transient suppression of appetite
(Deighton et al. 2014; King et al. 2010; King et al. 1994), a phenomenon termed “exercise-induced
anorexia” (Blundell et al. 2003), and is sometimes accompanied by post-exercise reductions in
free-living energy intake, though this is inconsistent (Schubert et al. 2013).
The majority of current research on appetite regulation has been performed in lean, young,
physically-active males, and while similar findings have been reproduced in the limited work
involving females (Alajmi et al. 2016; Hagobian et al. 2013; Howe et al. 2016; Panissa et al. 2016),
some sex differences have been identified (Hagobian et al. 2009; Hazell et al. 2017; Larson-Meyer
et al. 2012). Importantly, these differences have been demonstrated in work exclusively examining
females during the FP to control for the potential confounding effect of cycling E2 and P4
throughout the menstrual cycle (Alajmi et al. 2016; Hagobian et al. 2009; Hagobian et al. 2013;
Hallworth et al. 2017; Hazell et al. 2017; Larson-Meyer et al. 2012; Panissa et al. 2016). However,
the lack of research involving the LP prevents a complete understanding of appetite regulation in
humans, and particularly for identifying sex-based differences, as it is plausible to suggest that
other differences may emerge in the presence of a diverse hormonal environment. Only three
groups have examined the appetite-regulatory response during the LP (Brennan et al. 2009;
Campolier et al. 2016; McKie et al. 2018), and none have done so with exercise, which may present
different findings than those described above due to the characteristic fluctuations of E2 and P4
across the phases. Thus, the purpose of the current study was to utilize vigorous intensity
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continuous training (VICT), a mode of exercise demonstrated to increase plasma concentrations
of sex hormones post-exercise, as a mechanism to modulate E2 and P4 in normally menstruating,
premenopausal women and examine their associations with acylated ghrelin, PYY3-36, active GLP1, subjective appetite perceptions, and free-living energy-intake post-exercise in both the FP and
LP of the menstrual cycle.

Methods
Participants
Sixteen females volunteered to participate in this study. Participants were eumenorrheic
(having a regularly occurring menstrual cycle lasting within a range of 24-35 d, where cycle length
within each participant varied by only 1-2 d) for a minimum of 1 y (Lebrun et al. 1995), and
menstruating for a minimum of 3 y (Middleton et al. 2006). All participants were non-smokers,
deemed "healthy" as per the CSEP Get Active Questionnaire (GAQ; Appendix A), and
recreationally active, defined as no more than three exercise sessions per week and not involved
in any structured training program within four months of study participation. Participants were
excluded from participating in the study if they had been pregnant in the past 3 y or had plans to
become pregnant during the time of study participation, used hormonal oral contraceptives within
the past 6 months, or had a diagnosis of any eating disorders or metabolic diseases such as diabetes.
Participants provided a detailed history of their menstrual cycle for a minimum of the past
3 cycles. Day 1 of the menstrual cycle was defined as the onset of menses, and thereafter menstrual
phase was subject-monitored through the use of ovulation kits to identify a surge in LH.
Participants were provided with a urinary LH surge detection kit (Easy@Home, Easy Healthcare
Corporation, IL, USA) and were provided with detailed instructions on when to begin testing (as
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per manufacturer’s instructions), how to use the kit, as well as a PDF of the user manual for
reference. Menstrual phase was additionally monitored by oral body temperature upon awakening,
where a sustained increase of ~0.3°C was indicative of ovulation (Forsyth et al. 2008).
Temperature and LH testing outcomes were reported daily to the researcher via text/email, and
phase was confirmed with subsequent hormonal testing of plasma E2 and P4 on study days. Prior
to study initiation, experimental procedures were explained in detail and all participants provided
written informed consent. Ethical approval was obtained from the Wilfrid Laurier University
Ethics Committee for Research on Human Subjects in accordance with the 1964 Declaration of
Helsinki.

Study Design
Participants completed two separate experimental sessions (~4 h each) in a randomized,
counterbalanced order. Experimental sessions consisted of a running-based VICT protocol (80%
𝑉̇ O2max) performed in each the FP and LP. Blood samples and subjective appetite perceptions
were obtained at four time points during each experimental session at 0900 h (#1), 0950 h (#2),
1020 h (#3), and 1120 h (#4). Participants were instructed to record energy intake (quantity of
food intake and beverage consumption) for a 3-day period in a provided food log, including the
day prior to, the day of, and the day following testing. The dietary intake was then replicated in
the 24 h prior to the next experimental session.

Pre-experimental Procedures
All participants completed one familiarization session prior to the first experimental
session, in which they were screened for exclusion criteria and introduced to the study protocol
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and equipment. Participants performed a graded exercise test to exhaustion on a motorized
treadmill (4Front, Woodway, WI, USA) for the determination of 𝑉̇ O2max. Oxygen consumption
(𝑉̇ O2) and carbon dioxide production (𝑉̇ CO2) were measured continuously using an online breathby-breath gas collection and analysis system (MAX II, Aenergy intake technologies, Pittsburgh,
PA, USA).

Prior to data collection the gas analyzer was calibrated with gases of known

concentrations and with a 3-L syringe for flow. Each participant was fitted with a silicon facemask
(7400 series Vmask, Hans Rudolph Inc. KS, USA) to ensure comfort and prevent leaking during
gas measurements. Heart rate (HR) was recorded using an integrated HR monitor (FT1, Polar
Electro, QC, Canada). Participants began the test with a standardized 5 min warm up (3.5 mph),
after which they ran at a self-selected pace between 5-7 mph for the remainder of the test.
Incremental increases in grade (2%) were applied every two min until volitional fatigue. After a
20-min rest period, a verification phase was performed to ensure confidence in the obtained 𝑉̇ O2max
value. Participants ran at 110% of the maximal work rate obtained in the previous test until
volitional fatigue. 𝑉̇ O2max was defined as the greatest 30 s average at which 𝑉̇ O2 values plateaued
despite increases in workload. Alternatively, two of the following criteria were met: 1) respiratory
exchange ratio (RER) > 1.10, 2) maximal HR within ±10 bpm of age-predicted maximum (defined
as 220 – age), or 3) voluntary exhaustion. Upon determination of 𝑉̇ O2max, ~80% of this value was
calculated as the target intensity during the VICT protocol. Following the 𝑉̇ O2max test, participants
were acclimatized to the equipment as well as to the efforts required during the exercise protocol
to reduce any learning effects in subsequent sessions.
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Experimental Sessions
Prior to all experimental sessions, participants were asked to refrain from physical activity,
alcohol, and caffeine for 12 h. Participants arrived at the laboratory at 0800 h after a 12 h overnight
fast and remained in the laboratory for the following ~4 h (Figure 1). Upon arrival, a standardized
breakfast was provided (Chocolate chip Clif bar, 29 kJ·kg-1 body weight), which participants were
given 15 min to consume and 45 min to digest. Water was provided ad libitum throughout the
session. Exercise commenced at 0910 h and consisted of a 5-min standardized warm-up (3.5 mph),
a 30 min running-based VICT protocol, and a 5 min cool-down. Gas exchange (𝑉̇ O2 and 𝑉̇ CO2)
was measured continuously throughout exercise with the gas collection system and HR monitor.
Venous blood samples were obtained at four time points, including 0900 h (pre-exercise), 0950 h
(immediately post-exercise), 1020 h (30 min post-exercise), and 1120 h (90 min post-exercise).
Perceptions of appetite were assessed at the same blood-sampling time points using a visual
analogue scale (VAS, Appendix B).

Figure 1: Visual representation of experimental session timeline. VAS = visual analogue scale.
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Exercise Protocols
All exercise was performed on a motorized treadmill (4Front, Woodway, WI, USA) and
consisted of 30 min of continuous running at a target workload of 80% 𝑉̇ O2max. A pre-determined
work rate was used at the start, calculated using the 𝑉̇ O2 reserve method (Swain 2000). First, the
target 𝑉̇ O2 was determined by the following formula:
target 𝑉̇ O2 = (intensity fraction)(𝑉̇ O2max - 𝑉̇ O2rest) + 𝑉̇ O2rest
Then, a mode-specific standardized equation (the ACSM running equation) was used to determine
the percent grade necessary to elicit the target 𝑉̇ O2 at each participants chosen speed (Swain 2000):
𝑉̇ O2 = 0.2 (speed) + 0.9 (speed)(grade) + 3.5
Thereafter, 𝑉̇ O2 was continuously monitored, and work rate adjusted using speed and grade as
needed to maintain the target intensity.

Blood Sampling Protocol
Venous blood samples were collected from an antecubital vein while participants were in
a supine position for the determination of plasma acylated ghrelin, active GLP-1, PYY3-36, E2, and
P4. Two 3 mL whole blood samples were collected into separate pre-chilled Vacutainer tubes
coated with K2 ethylenediaminetetraacetic acid (EDTA; 5.4 mg) at each time point. To prevent
degradation

of

acylated

ghrelin

by

proteolytic

enzymes,

120

µL

of

4-(2-

aminoethyl)benzenesulfonyl fluoride hydrochloride (AEBSF) was added to whole blood
immediately after sample collection in one tube. In the secondary tube, 30 µL of DPP-IV inhibitor
was added to prevent inactivation of active GLP-17-36,

7-37

and ex-vivo conversion of PYY1-36 to

PYY3-36, and 128 µL of aprotinin was added to prevent the degradation of PYY3-36 by proteolytic
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enzyme activity. E2 and P4 samples were analyzed from blood samples containing AEBSF (McKie
et al. 2018). All tubes were gently inverted 10 times and centrifuged at 3000 g for 10 min at -4°C,
after which the plasma supernatant was aliquoted into microcentrifuge tubes. Plasma from the
acylated ghrelin vacutainer was acidified by the addition of 100 µL of HCl per 1 mL of plasma
(Islam et al. 2017).

All samples were stored at –80°C for subsequent analysis, whereby

commercially available enzyme-linked immunosorbent assays (ELISA) were conducted to
determine plasma concentrations of acylated ghrelin, active GLP-1, PYY3-36, E2, and P4 as per
manufacturer’s instructions. All samples were analyzed in duplicate, except for a random 25%
which were run in triplicate, and batch analyzed for each participant to eliminate inter-assay
variation. The intra-assay coefficients of variation for E2, P4, acylated ghrelin, PYY3-36, and active
GLP-1 were 9.1, 10.5, 12.4, 8.4, 6.51, and 4.2%, respectively.

Appetite Perceptions
Appetite perceptions were assessed using a visual analog scale (VAS) that has been
validated (Flint et al. 2000) and used in past research with both men (Islam et al. 2017) and women
(Brennan et al. 2009). The scale consists of seven items and assesses participants’ perceptions of
hunger (i.e. “How hungry do you feel?”), satisfaction (i.e. “How satisfied do you feel?”), fullness
(i.e. “How full do you feel?”), and prospective food consumption (i.e. “How much do you think
you can eat?”). Additional questions include: “How often do you eat breakfast in the morning?”,
“How anxious do you feel?”, and “How nauseous do you feel?”. Participants indicated their
responses by reporting on a 100 mm scale with opposing statements (i.e. “not at all” and
“extremely”) at each end.
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Energy Intake
Free-living energy intake was recorded for a 3-day period using self-reported dietary logs
that were provided to each participant (Appendix C). On the day prior to an experimental session,
participants were asked to begin recording their energy intake, and continue recording until the
end of the day following the session. Participants were instructed to replicate their intake on the
day prior to all subsequent sessions and were provided with a copy of their dietary log for that day.
Detailed instructions were provided, including a sample log, to ensure accurate measurement and
recording. Nutribase software (Nutribase Pro Edition, Cybersoft Inc., AZ, USA) was used to
analyze all dietary logs for total energy intake (kcal) and macronutrient content each day.

Statistical Analysis
All data were analyzed using GraphPad PRISM (GraphPad Software, La Jolla, CA, USA).
Paired samples t-tests were used to compare absolute pre-exercise acylated ghrelin, active GLP-1,
PYY3-36, E2, and P4 concentrations across the FP and LP, as well as absolute VAS scores at baseline
and total energy intake (kcal) on the day prior to each experimental session. A series of two-factor
(phase x time) repeated measures analyses of variance (RM ANOVAs) were conducted to compare
changes in hormonal concentrations at each time point, as well as changes in appetite perceptions
over time. Two-factor (phase x day) RM ANOVAs were used to compare changes in free-living
energy intake on the day of and day after experimental sessions. Where significant main effects
were found, post-hoc analyses using Tukey’s HSD test were performed. Due to the individual
variability of fasting absolute hormone concentrations between participants, changes at each time
point for appetite-regulatory hormones were expressed as relative to each participants’ preexercise values as described previously (Gibbons et al. 2013). Sex hormones are presented as
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absolute values due to the expected differences between phases. The area under the curve (AUC)
for blood-related parameters and appetite perceptions were calculated using the trapezoidal
method, and all AUC values were compared via paired samples t-tests across the FP and LP.
Pearson product-moment correlations were used to assess relationships between sex hormones and
appetite regulatory hormones. Effect sizes were calculated using Cohen’s d and Cohen’s f for
paired-samples t-tests and RM ANOVAs, respectively. Statistical significance was set at P<0.05,
and all data are presented as mean±standard deviation.

Results
Participant Characteristics
A total of sixteen participants were recruited and successfully completed the familiarization
session.

However, one individual completed her first experimental session and then withdrew

from the study, while four others withdrew after completing the familiarization session. Thus,
eleven women successfully completed all experimental sessions.

Due to time constraints,

hormonal data presented are for eight participants, while the remaining appetite and energy intake
data are for eleven. Participants were 22±4 years of age with a mean 𝑉̇ O2max of 37.02±4.04 mL∙kg1

∙min-1 (2.28±0.40 L∙min-1) and the following physical characteristics: height 163.39±4.37 cm;

weight: 61.95±10.60 kg; and BMI: 23.34±3.75 kg/m2. Regarding the 𝑉̇ O2max test, 8 of 11
participants exhibited a plateau in 𝑉̇ O2 uptake, defined as less than half of the expected increase in
𝑉̇ O2 between subsequent stages (<1.35 mL∙kg-1∙min-1; Taylor et al. 1955). The remaining 3 reached
87.7% of the expected increase between the final two stages, however they satisfied at least two
of the secondary criteria in the absence of a plateau. At the termination of their tests, these
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participants had RER values of 1.17, 1.17 and 1.16, with heart rates of 200, 197, and 187 bpm,
respectively. No verification phase exceeded the maximum value obtained on the 𝑉̇ O2max test.
The mean 𝑉̇ O2max of the five individuals who withdrew from the study (38.58±3.63
mL∙kg-1∙min-1) was very similar to the participants who completed all experimental sessions,
suggesting there was no difference in cardiorespiratory fitness between the two groups.

Exercise Responses
The 30-min VICT sessions in the FP and LP were completed at a work rate corresponding
to 29.31±3.30 mL∙kg-1∙min-1 (79.3±0.03% 𝑉̇ O2max) and 29.42±3.10 mL∙kg-1∙min-1 (79.6±0.02%
𝑉̇ O2max), respectively, and were not significantly different between phases (t(10)=0.324, P=0.753,
d=-0.10). There were no significant differences in the average heart rate during VICT in the FP
(171±15 bpm) and LP (171±12 bpm; t(10)=0.127, P=0.902, d=-0.01), or in RER values during
VICT in the FP (1.01±0.05) and the LP (1.00±0.04; t(10)=2.13, P=0.058, d=0.64). 𝑉̇ O2-derived
estimates of energy expenditure (assuming a relationship of 5 kcal/L O2) were 270.9±36.0 kcal
and 272.5±45.5 kcal in the FP and LP, respectively, and were not significantly different between
phases (t(10)=0.662, P=0.523, d=-0.20).

Estradiol
All subjects reported regular menstrual cycles ranging 24-35 d in length. Average testing
occurred on day 8±1.4 for the FP, and day 22±2.5 for the LP. There were no significant differences
in the baseline concentrations of E2 between the FP (52.72±12.79 pg∙mL-1) and LP (76.82±28.46
pg∙mL-1; t(7)=1.99, P=0.086, d=-0.70). Two-factor (phase x time) repeated measures ANOVA
revealed no significant interaction (F(3,21)=0.44, P=0.727, f=0.25) for absolute changes in E2 over
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time (Figure 2). There was no main effect of phase (F(1,7)=4.4, P=0.074, f=0.79), however there
was a main effect of time (F(3,21)=3.6, P=0.031, f=0.71), whereby E2 was greater immediately postexercise (76.72±34.15 pg∙mL-1) compared to pre-exercise (63.32±23.80 pg∙mL-1; P=0.041). AUC
values were not different between phases (Figure 2; t(7)=0.22. P=0.830, d=-0.08).

Figure 2: Absolute changes in E2 across all time points (left) and area under the curve (AUC)
values for E2 (right). Note: FP: follicular phase; LP: luteal phase. * - POST significantly greater
than PRE when collapsed across phases.

Progesterone
There were significant differences in the baseline concentrations of P4 between phases,
such that concentrations in the FP were significantly lower (3.07±1.76 ng∙mL-1) compared to the
LP (12.28±6.14 ng∙mL-1; t(7)=2.47, P=0.043, d=-0.87). Two-factor (phase x time) repeated
measures ANOVA revealed no significant interaction (F(3,21)=0.39, P=0.764, f=0.23) for absolute
changes in P4 over time (Figure 3), however, there was a main effect of both phase (F(1,7)=9.9,
P=0.016, f=1.19) and time (F(3,21)=3.6, P=0.031, f=0.72). As expected, P4 levels were significantly
greater in the LP compared to the FP. Despite a significant main effect of time, no significant
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differences were found following post-hoc analysis at any time point when phase was collapsed.
AUC values were not different between phases (Figure 3; t(7)=0.22. P=0.528, d=-0.23).

Figure 3: Absolute changes in P4 across all time points (left) and area under the curve (AUC)
values for P4 (right). Note: FP: follicular phase; LP: luteal phase. * - significantly greater than FP.

Acylated Ghrelin
There was no significant difference in the baseline concentrations of acylated ghrelin across
the FP and LP (t(7)=1.92, P=0.097, d=-0.68). Two-factor (phase x time) repeated measures
ANOVA revealed no significant interaction (F(3, 21)=1.2, P=0.339, f=0.41) for changes in acylated
ghrelin relative to baseline (Figure 4). There was a main effect of phase (F(1, 7)=7.5, P=0.029,
f=1.03), such that acylated ghrelin concentrations were significantly lower in the FP (138.24±87.81
pg∙mL-1) compared to the LP (206.84±137.02 pg∙mL-1, P=0.002). In addition, there was a main
effect of time (F(3,

21)=5.4,

P=0.007, f=0.87), whereby acylated ghrelin concentrations were

significantly greater at 90 min post-exercise (243.27±175.24 pg∙mL-1) compared to both
immediately post- (136.96±86.80 pg∙mL-1; P=0.036) and 30 min post-exercise (136.92±86.70
pg∙mL-1; P=0.014). AUC values for acylated ghrelin (Figure 4) were not different between phases
(t(7)=1.15, P=0.289, d=-0.41).
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Figure 4: Changes in acylated ghrelin across all time points relative to baseline (left) and area
under the curve (AUC) values for acylated ghrelin (right). Note: FP: follicular phase; LP: luteal
phase; FP* – significantly different from LP; * - 90-POST significantly greater than POST and
30-POST when collapsed across phases.

PYY3-36
There was no significant difference in the baseline concentrations of PYY3-36 across the FP
and LP (t(7)=0.47, P=0.652, d=-0.16). Two-factor (phase x time) repeated measures ANOVA
revealed no significant interaction (F(3, 21)=0.12, P=0.948, f=0.13) for changes in PYY3-36 relative
to baseline (Figure 5). There was no main effect of phase (F(1, 7)=0.001, P=0.973, f=0.18) or time
(F(3, 21)=1.3, P=0.305, f=0.41). AUC values for PYY3-36 (Figure 5) were not different between
phases (t(7)=0.10, P=0.926, d=0.04).
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Figure 5: Changes in PYY3-36 across all time points relative to baseline (left) and area under the
curve (AUC) values for PYY3-36 (right). Note: FP: follicular phase; LP: luteal phase.

Active GLP-1
There was no significant difference in the baseline concentrations of active GLP-1 across
the FP and LP (t(7)=0.47, P=0.654, d=0.17). Two-factor (phase x time) repeated measures ANOVA
revealed no significant interaction (F(3, 21)=1.55, P=0.238, f=0.47) for changes in active GLP-1
relative to baseline (Figure 6). There was no main effect of phase (F(1, 7)=1.35, P=0.284, f=0.44),
however there was a main effect of time (F(3, 21)=3.8, P=0.026, f=0.73), whereby active GLP-1
concentrations were significantly elevated 30 min post-exercise (14.62±4.44 pM∙mL-1) compared
to 90 min post-exercise (8.86±3.47 pM∙mL-1; P=0.016). AUC values for GLP-1 (Figure 6) were
not different between phases (t(7)=0.33, P=0.749, d=0.13).
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Figure 6: Changes in active GLP-1 across all time points relative to baseline (left) and area under
the curve (AUC) values for GLP-1 (right). Note: FP: follicular phase; LP: luteal phase.
* - 30-POST significantly greater than 90-POST when collapsed across phases.

Appetite Perceptions
There were no differences in absolute VAS scores pertaining to overall appetite (t(10)=0.75,
P=0.475, d=0.16) between the FP and LP at baseline. Two-factor (phase x time) repeated measures
ANOVA revealed no significant interaction (F(3, 30)=0.61, P=0.616, f=0.25) for changes in overall
appetite relative to baseline (Figure 7). There was also no main effect of phase (F(1, 10)=1.5,
P=0.245, f=0.34), but there was a main effect of time (F(3, 30)=14, P<0.001, f=1.17). Specifically,
overall appetite was greater at 90 min post-exercise (66.19±19.59) compared to pre-exercise
(41.95±21.63, P<0.001), immediately post-exercise (37.13±27.05, P<0.001), and 30-min postexercise (50.81±25.09, P=0.023) when collapsed across phases. AUC values for overall appetite
(Figure 7) were not different between phases (Figure 7; t(10)=1.11, P=0.292, d=0.32). The results
for each individual appetite perception can be found in Appendix D.
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Figure 7: Changes in overall appetite across all time points relative to baseline (left) and area
under the curve (AUC) values for overall appetite (right). Note: FP: follicular phase; LP: luteal
phase. * - 90-POST significantly greater than PRE, POST, and 30-POST when collapsed across
phases.

Energy Intake
There were no differences in energy intake between phases on the day prior to the
experimental session (t(9)=1.91, P=0.089, d=0.60), as was intended (Table 1). Two-factor (phase
x day) repeated measures ANOVA revealed no significant interaction (F(2, 18)=0.15, P=0.859,
f=0.13) for changes in energy intake across the day before, day of, and day after experimental
sessions (Figure 8). There was no main effect of phase (F(1, 9)=0.54, P=0.481, f=0.24) or day (F(2,
18)=1.5,

P=0.244, f=0.40).
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Table 1. Energy and macronutrient intake on the day prior to each experimental session.
FP
LP
Total energy intake (kcal)
1793.7±566.3
1757.7±553.3
Carbohydrate (g)
204.8±96.5
202.5±95.2
(%)
54.2±0.2
54.4±0.1
Fat (g)
75.2±28.1
74.1±25.4
(%)
21.9±0.1
21.9±0.1
Protein (g)
78.9±30.8
76.50±27.4
(%)
24.0±0.1
23.7±0.1
Note: FP: follicular phase; LP: luteal phase

Figure 8: Total energy intake (kcal) on the day before, day of, and the day after each experimental
session. Note: FP: follicular phase; LP: luteal phase.

Correlations
E2 was positively correlated with acylated ghrelin at 90 min post-exercise in the FP (Table
2; r = 0.88, P=0.004), while P4 was positively correlated with active GLP-1 at baseline in the FP
(r = 0.78, P=0.022). There were no significant correlations at any other time point in either phase.
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Table 2. Correlations between sex hormones and appetite-regulatory hormones.
E2
PRE
POST
30-POST
90-POST
Acylated ghrelin
FP
0.14
0.56
0.57
0.88*
LP
-0.02
-0.11
0.35
0.13
PYY3-36
FP
0.22
0.20
0.03
-0.19
LP
-0.42
-0.20
0.11
0.37
Active GLP-1
FP
0.02
0.41
-0.38
-0.17
LP
-0.07
-0.16
-0.04
-0.17
P4
PRE
POST
30-POST
90-POST
Acylated ghrelin
FP
-0.26
-0.32
-0.40
-0.03
LP
-0.06
-0.28
0.18
-0.02
PYY3-36
FP
0.01
0.26
0.23
-0.29
LP
-0.19
-0.12
0.20
0.30
Active GLP-1
FP
0.78*
-0.06
0.47
0.21
LP
0.19
-0.56
0.35
-0.07
Note: Values are in Pearson’s correlation coefficients (r). FP: follicular phase; LP: luteal phase
*P<0.05

Figure 9: Pearson product-moment correlations (r) between E2 and acylated ghrelin at 90 min
post-exercise in the FP (left), and P4 with active GLP-1 at baseline in the FP (right).
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Discussion
The difficulties females experience with fat loss from exercise may be due to characteristic
changes in E2 and P4 across the menstrual cycle, as these hormones coincide with changes in
energy intake between phases and may be involved in the appetite-regulatory response to exercise.
However, appetite regulation in females has been exclusively studied in the FP of the menstrual
cycle where concentrations of E2 and P4 are low (Alajmi et al. 2016; Hagobian et al. 2009;
Hagobian et al. 2013; Hallworth et al. 2017; Hazell et al. 2017; Larson-Meyer et al. 2012; Panissa
et al. 2016), and the effects of greater concentrations of sex hormones in the LP on appetiteregulatory hormones is unknown. As such, the current investigation utilized vigorous running for
30 min at 80% 𝑉̇ O2max between the FP and LP in healthy, recreationally active, naturally
menstruating pre-menopausal women to examine exercise-induced increases in E2 and P4 and their
associations with alterations in appetite-regulatory hormones. The main findings of this study are:
a) E2 was significantly elevated immediately post-exercise, however P4 was unaffected by VICT
in both phases, b) acylated ghrelin was significantly lower in the FP compared to the LP,
suggesting a selective post-exercise suppression in the FP only c) active GLP-1 concentrations
were significantly elevated at 30 min post-exercise compared to 90 min post-exercise, and d)
neither PYY3-36, overall appetite, nor energy intake appeared to be affected by exercise or
menstrual cycle phase.

Estradiol and Progesterone
As a major objective of this project was to observe the appetite-regulatory response to
exercise in the LP, confidence that testing occurred in the correct phases is required. Though there
were no significant differences in the baseline concentrations of E2 between the FP (53.08±12.79
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pg∙mL-1) and LP (73.57±28.46 pg∙mL-1), concentrations are in accordance with accepted values
for each phase (Allen et al. 2016), and is similar to previous research where a significant difference
between phases was not observed (Brennan et al. 2009; Reed et al. 2008). Baseline concentrations
of P4 in the FP are greater than the accepted values for this phase (Allen et al. 2016), suggesting
that testing may have occurred in the mid- to late-FP, when concentrations of P4 begin to rise,
though they were significantly lower (3.07±1.76 ng∙mL-1) compared to the LP (12.28±6.14 ng∙mL1

). On average, experimental sessions during the FP occurred on day 8 of the cycle, with the latest

day tested on day 10, as is common practice in other work (Brennan et al. 2009; Campolier et al.
2016; Hallworth et al. 2017). Plasma concentrations of P4 in the LP are in accordance with the
accepted values for this phase (Allen et al. 2016), and significant differences between phases are
reflected in previous literature (Brennan et al. 2009).
Despite the baseline values and in accordance with our hypotheses, VICT elevated plasma
concentrations of E2 in both the FP and LP immediately post-exercise, demonstrating an increase
of 15.97% and 24.90%, respectively, before declining close to baseline values at 30 min postexercise. These magnitudes of change from baseline following vigorous-intensity exercise follow
similar trends, albeit are slightly lower than that which has been presented in previous research at
25.05% and 35.39% in the FP and LP, respectively (Jurkowski et al. 1978), as are the
concentrations we observed (Bonen et al. 1991; Jurkowski et al. 1978). Interestingly, our absolute
changes are in line with those that occurred with light-intensity (Jurkowski et al. 1978) or
moderate-intensity exercise (Redman et al. 2003) in both phases, as well as following moderateintensity exercise in the FP (Jurkowski et al. 1978), though lesser changes in the LP. Despite these
differences, our data appear to support the use of VICT as a mechanism to increase plasma
concentrations of E2 following exercise in each phase.
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Contrary to our hypothesis, P4 was not elevated in response to VICT in the LP. No
significant differences were found following post-hoc analysis of P4 (despite a main effect of time),
though there was a trend for an increase in P4 from pre- to post-exercise (P=0.078) with a medium
effect size (f=0.62), suggesting an important increase may have occurred that appears to be driven
by the post-exercise change in the LP compared to the FP (Figure 3). The magnitudes of change
in P4 observed following exercise in the FP and LP were 28.39% and 32.37%, respectively, and
again, follow similar trends to previous research. The absolute changes we observed are greater
than that which has been observed following light-intensity (Jurkowski et al. 1978; Redman et al.
2003) and moderate-intensity exercise (Bonen et al. 1979; Redman et al. 2003), and are in line
with previous work following vigorous-intensity exercise (Jurkowski et al. 1978), though slightly
lower than others (Bonen et al. 1991). Though similar to past work, it should be noted that absolute
changes in P4 were marginal in each phase, and the practical importance of such changes remains
to be elucidated. A key methodological difference between our study and those aforementioned
is the nature of the exercise bout, as exercise intensity gradually increased over time in previous
work (Bonen et al. 1991; Bonen et al. 1979; Jurkowski et al. 1978; Redman et al. 2003), whereas
our protocol involved a consistent intensity over 30 minutes. Thus, it is possible that the greater
absolute changes observed in other work were due to a combination of an intensity and duration
effect, and lesser magnitudes observed in our work are due to the shorter amount of time spent
exercising. Future research should seek to distinguish between these effects, examining the
ovarian hormonal response to acute sessions of exercise at various intensities.
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Acylated Ghrelin
Contrary to our first hypothesis, we observed no significant suppression of acylated
ghrelin immediately post-exercise in the FP (81.71±38.96 pg∙mL-1) compared to baseline
(145.78±31.58 pg∙mL-1; P=0.157), though the effect size was large (d=1.53). However, together
with the main effect of phase, whereby acylated ghrelin concentrations were significantly lower in
the FP (138.24±87.81 pg∙mL-1) compared to the LP (206.84±137.02 pg∙mL-1), the 64.07 pg∙mL-1
difference in plasma ghrelin concentrations from pre-post exercise in the FP compared to the 8.04
pg∙mL-1 difference in the LP suggests a meaningful suppression occurred in the FP only. Few
others have examined acylated ghrelin responses to exercise in women, and our observation is
comparable to previous work in the FP demonstrating significant reductions in acylated ghrelin
following 60 minutes of running at 70% 𝑉̇ O2max (Alajmi et al. 2016), HIIT performed at 100%
𝑉̇ O2max and “all-out” SIT (Panissa et al. 2016), and following isocaloric bouts of running performed
at 60 and 85% 𝑉̇ O2max (Howe et al. 2016) during the FP in women. However, others have also
reported increased (Hagobian et al. 2009; Larson-Meyer et al. 2012) or no change (Douglas et al.
2017; Hagobian et al. 2013) in acylated ghrelin following both running and cycling exercise
performed at low (~50-65% 𝑉̇ O2peak) to moderate (70-75% 𝑉̇ O2peak) intensities, demonstrating a
lack of consensus in the literature that is exclusively represented by research in the FP.
Similarly, in the LP, we observed no change in acylated ghrelin immediately post-exercise
(192.22±87.45 pg∙mL-1) compared to baseline (200.26±100.35 pg∙mL-1; P=0.999, d=0.15),
demonstrating no effect of VICT during the LP. This finding is in contrast to the majority of
literature exhibiting a transient suppression of acylated ghrelin post-exercise (Schubert et al. 2014)
and particularly following exercise of greater intensities, as acylated ghrelin has been shown to
decrease in a dose-response fashion (Islam et al. 2017), though this trend is based on literature
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performed in males only. As discussed above, the research in females is less consistent and there
is no general consensus regarding the effect of acute exercise on acylated ghrelin specifically in
women, highlighting the importance of studying appetite across the menstrual cycle. Our novel
observation of acylated ghrelin in the LP compared to the response in the FP suggests that the
appetite-suppressive effect of exercise may be blunted in the presence of greater concentrations of
sex hormones during the LP. This finding is in line with the suggestion that women demonstrate
greater adaptive responses to energy deficits as a mechanism to preserve reproductive functions,
body fat stores, and energy balance (Hagobian et al. 2010; Hagobian et al. 2009; Wade et al. 2004),
and particularly due to this finding occurring during the LP when the body is preparing to maintain
pregnancy. Alternatively, production of acylated ghrelin in the FP may be impacted by E2, as
decreased numbers of ghrelin-producing cells, ghrelin mRNA concentrations, and plasma
concentrations of ghrelin have been observed following exogenous E2 administration in
ovariectomized rats (Matsubara et al. 2004). This suggestion appears to be supported with our
observed trend (P=0.097, d=-0.68) of higher baseline concentrations of acylated ghrelin in the LP
(200.26±100.35) vs. the FP (145.78±31.28), though this difference in baseline values between
phases has not been reproduced in other work (Dafopoulos et al. 2009; McKie et al. 2018), and the
two were not correlated post-exercise, making establishing a relationship between these variables
challenging. Independent of phase, we observed a significant elevation of acylated ghrelin at 90
min post-exercise (243.27±175.24 pg∙mL-1) compared to both immediately-post (136.96±86.80
pg∙mL-1) and 30 min post-exercise (136.92±86.70 pg∙mL-1), as is expected due to the rise in
acylated ghrelin that occurs during periods of fasting (Murphy and Bloom 2006).
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PYY3-36
Contrary to our hypotheses, VICT did not affect PYY3-36 in either phase, as we observed
no change immediately post-exercise (0.55±0.15 ng∙mL-1) vs. pre-exercise (0.51±0.13 ng∙mL-1).
This finding is in contrast to the only other report examining the effect of VICT on appetiteregulatory hormones in females demonstrating a significant increase in PYY3-36 following a bout
of running at 85% 𝑉̇ O2max (Howe et al. 2016), and to other work suggesting a greater post-exercise
increase in women compared to men (Hagobian et al. 2013). However, as with acylated ghrelin,
the research in females is limited, and other studies examining the impact of acute exercise of
various intensities on PYY3-36 and total PYY in females have produced equivocal findings of
increased (Hagobian et al. 2013; Hazell et al. 2017; Larson-Meyer et al. 2012) or
unchanged (Alajmi et al. 2016; Hallworth et al. 2017; Panissa et al. 2016) concentrations postexercise. Of note is the apparent sex difference in the total PYY response following MICT (30
min cycling at 65% 𝑉̇ O2max) and SIT (six 30 s “all-out” efforts), where males demonstrated a
greater post-exercise increase compared to females in the FP (Hagobian et al. 2013; Hazell et al.
2017; Larson-Meyer et al. 2012). The lack of response to exercise demonstrated in females is in
line with the current study, as exercise of a vigorous intensity did not alter PYY3-36 post-exercise
in either phase. Our novel observation in the LP suggests that neither exercise nor sex hormones
appear to affect PYY3-36, however further research is required to determine the reproducibility of
our findings and reconcile the discrepancies with previous literature. Though preliminary, the lack
of response to exercise in the LP is also in line with the hypothesis of preservation of reproductive
function, as it would suggest that exercise is not successful in creating (or maintaining) an
anorexigenic environment during a period of time important to child-bearing in women. Similarly,
it has been suggested that the anorexigenic effects of E2 are blunted in the presence of P4, further
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promoting an orexigenic environment in this phase (Frankovich and Lebrun 2000). However, this
speculation must be interpreted with caution, as we also did not observe an increase in PYY3-36 in
the FP, a time when energy intake tends to be lower in females, and no correlations were observed
between sex hormones and PYY3-36.

Active GLP-1
There were no differences in baseline concentrations of active GLP-1 between phases, as
has been described in previous work in total GLP-1 (Brennan et al. 2009). Interestingly, active
GLP-1 concentrations were significantly elevated at 30 min post-exercise (14.62±4.44
pmol∙mL-1) compared to 90 min post-exercise (8.86±3.47 pmol∙mL-1), which is in partial
accordance with our hypothesis, albeit delayed as we hypothesized an increase would occur
immediately post-exercise. The increase in active GLP-1 appears to be an exercise-induced effect
due to the well-established fluctuations of GLP-1 between meals, such that plasma concentrations
rise after a meal and are reduced with fasting (Murphy and Bloom 2006). However, other reports
demonstrating an increase in total GLP-1 in females occurred immediately post-exercise
(Hallworth et al. 2017; Howe et al. 2016; Larson-Meyer et al. 2012; Martins et al. 2007) and our
observation of a delayed elevation has not been reported elsewhere. It is important to note that all
prior observations of GLP-1 in females involved total GLP-1, whereas the present study measured
active GLP-1. It is possible that this distinction underlies the discrepancy in results, as alternative
forms of this peptide may respond differently to acute exercise (Hazell et al. 2016), though future
work is warranted.
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As with PYY, a distinct sex difference in the GLP-1 response to acute exercise has been
observed in previous work, where total GLP-1 increased immediately following both MICT (30
min cycling at 65% 𝑉̇ O2max) and SIT (six 30 s “all-out” efforts) compared to control levels in
females only (Hagobian et al. 2013; Hazell et al. 2017; Larson-Meyer et al. 2012). Similar to
PYY, Hazell and colleagues’ observation of GLP-1 in the FP is in line with our current findings,
demonstrating an increase in active GLP-1 regardless of phase, despite the difference in timecourse.

Appetite Perceptions and Energy Intake
Contrary to our hypotheses, we observed no difference in overall appetite between the FP
and LP, nor did we observe the well-described phenomenon of “exercise-induced anorexia” that
typically occurs concomitantly with post-exercise decreases in acylated ghrelin and increases in
satiety hormones (Deighton and Stensel 2014; Dorling et al. 2018). Similarly, no differences in
free-living energy intake on the day of, or on the day following exercise were observed, and no
differences between phases were found. Although many studies report simultaneous changes in
these parameters, the divergence of the appetite hormone and perceptual response is not unique
and has been reported at the group level in previous literature (Deighton et al. 2013; Martins et al.
2015; Sim et al. 2014). Furthermore, divergent responses at the individual level (despite a
significant group change) has been highlighted in recent work examining individual variation in
appetite suppression (Goltz et al. 2018), in addition to demonstrating true variability in the
magnitude of the responses to exercise. As such, it is possible that some participants may have
demonstrated the typical concomitant change in appetite hormones and perceptions while the
majority of participants demonstrated a divergent response, resulting in the lack of overall change.
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However, we are unable to assess individual variability in the current study due to the chosen
experimental design of a single pair of trials (Hopkins 2015). Alternatively, it is possible that the
observed change in acylated ghrelin (and lack thereof in satiety hormones) in the current study was
not of sufficient magnitude to alter subjective appetite perceptions, and thus did not translate into
a decrease in overall appetite. Lastly, other variables not examined in the current study may have
influenced participants’ perceived appetite. In this regard, it is important to note that the human
appetite system is highly complex. Many other variables such as environmental cues or cognitive
states are known to affect the control of energy intake (Murphy and Bloom 2006; Stensel 2010),
and the hormonal response to exercise may be of lesser importance than other, non-homeostatic
variables (Hagobian et al. 2013). Seemingly in line with this notion, while reduced absolute energy
intake following an acute bout of exercise has been reported by others in males (Islam et al. 2017;
Sim et al. 2014), it is uncommon, as the majority of current evidence suggests that single bouts of
moderate- to high-intensity exercise do not alter free-living, absolute energy intake immediately
post-exercise (Schubert et al. 2014). There is less agreement about the effect of chronic exercise
on energy intake, as partial compensation (~30%) over a longer period of time (7 – 14 d) has been
reported in both males (Stubbs et al. 2004; Whybrow et al. 2008) and females (Stubbs et al. 2002),
suggesting more frequent bouts or longer exposures may be required to alter free-living energy
intake. Further work is necessary to elucidate the long-term changes to energy intake following
chronic exercise in both men and women.

Limitations
While this study provides valuable information regarding the effects of acute exercise on
appetite regulation across the menstrual cycle, it is important to highlight several limitations. As
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per the design of our study, we are unable to determine a causal relationship between sex hormone
concentration and changes observed to appetite-regulatory hormones across the phases, and
speculation of their involvement should be interpreted with caution. We did not examine energy
intake in each phase during a control period (i.e., without exercise), and thus are unable to compare
typical energy intake between phases due to the replication of 24 h intake between subsequent
sessions.

Though the timing of our sessions suggests data collection occurred during the

appropriate phases (day 8 vs. day 22 on average), the baseline concentrations of P4 in the FP
suggest testing occurred in the late FP, thus we did not achieve a comparison between the minimum
and peak values of this hormone, as was intended. Due to the relatively greater levels of P4
observed during the FP, testing should occur earlier in this phase to ensure the lowest levels of
both E2 and P4 are present, allowing for more accurate representations of the different responses
between phases. Slightly higher than desired intra-assay coefficients of variation (>10%) were
reported for P4 and acylated ghrelin, however we were unable to perform new assays due to time
constraints. This variability should be noted when interpreting the results, though is subject to
change with the addition of the remaining 3 participants. Furthermore, as we did not measure
hematocrit and hemoglobin, we were unable to correct exercise-induced changes in hormone
concentrations for plasma volume shifts with exercise (Dill et al. 1974), though there is no
consensus regarding the need for this procedure (Kargotich et al. 1998), and numerous appetite
studies have reported a negligible influence of this correction on their findings (Douglas et al.
2017; Goltz et al. 2018; King et al. 2015). Lastly, though we have 3 remaining participants to
include in the hormonal analysis, our sample size is relatively small, and their characteristics
(healthy, recreationally active, naturally menstruating) limit the generalizability of our findings to
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hormonal birth control users, post-menopausal women, overweight/obese, or sedentary
populations.

Conclusion
To the best of our knowledge, this is the first study to examine appetite-regulatory and sex
hormonal responses to VICT between the follicular and luteal phases of the menstrual cycle in
healthy, recreationally active, naturally menstruating women. We observed a transient increase in
E2 in both phases post-exercise, as well as a trend of increased P4 in the LP only. In addition, we
showed lower a concentration of acylated ghrelin in the FP compared to the LP, with a trending
suppression post-exercise that was phase-specific to the FP, potentially suggesting the acute
appetite-regulatory response to exercise is blunted in the LP of the menstrual cycle. Lastly, both
PYY3-36 and active GLP-1 responded similarly between phases, demonstrating no change or a
delayed increase at 30 min-post exercise, respectively, suggesting sex hormones may not play a
role in their responses to acute exercise. Given the small sample size of the current study, the
novelty of these observations, and the lack of other studies conducted in the LP, future work should
focus on the reproducibility of our findings to further elucidate the influence of sex hormones on
appetite regulation across the menstrual cycle.
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CHAPTER 3:
GENERAL DISCUSSION & FUTURE DIRECTIONS
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The current study examined the effects of acute exercise on acylated ghrelin, PYY3-36,
active GLP-1, subjective appetite perceptions, and free-living energy intake across the menstrual
cycle to examine whether the presence of elevated E2 and P4 in the LP (exacerbated by vigorousintensity exercise) influenced these effects. This work served as an important next step to previous
work identifying clear sex differences in the appetite-regulatory response to acute exercise
(Hagobian et al. 2009; Hazell et al. 2017; Larson-Meyer et al. 2012) and allowed us to more
accurately characterize this response in the female population by examining the LP, as research is
this field has been exclusively carried out in the FP. The results of this study contribute to a more
complete understanding of the relationship between exercise and appetite control by examining
females throughout the entire menstrual cycle, as per several important findings. We found that
the well-documented post-exercise suppression of acylated ghrelin (Schubert et al. 2014) may be
phase-dependent, as acylated ghrelin levels were significantly lower in the FP compared to the LP,
with a greater post-exercise suppression in the FP, suggesting a blunted response in the LP. In
addition, we found no observable effects of exercise on PYY3-36, overall appetite, or free-living
energy intake in either phase, as well as an increase in active GLP-1 at 30 min post-exercise
(relative to 90 min post) independent of phase, suggesting the presence of elevated E2 and P4 in
the LP does not influence these parameters. While these findings indicate menstrual cycle phase
may play only a small role in appetite regulation across the menstrual cycle, our results are
preliminary, and further work is necessary to explore these effects. In addition, there remain
several important points that must be highlighted in light of our findings.
First, we aimed to create a unique paradigm to examine the potential effects of ovarian sex
hormones on appetite-related parameters by implementing a vigorous-intensity exercise protocol
that would selectively increase plasma concentrations of P4 in the LP while increasing plasma E2
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in both the FP and LP, as per previous literature (Bonen et al. 1991; Jurkowski et al. 1978). In
doing so, we hoped to create an environment that would allow for a unique comparison of the
appetite-regulatory response in the presence of low P4 and increased E2 (the FP), and elevated
levels of both E2 and P4 (the LP). While these patterns are what naturally occurs in each respective
phase, it was our hope that the use of VICT would amplify these responses and allow for a clearer
distinction of any potential between-phase differences. Though we did not observe an exerciseinduced increase in P4 during the LP as was expected, the natural cycling of P4 between phases
(and confirmed significant differences in baseline concentrations) allowed for a comparison
between two distinct hormonal environments, as was the main objective of the overall project. In
addition, if sex differences in the relationship between exercise and appetite hormones manifest
only concurrently with peak concentrations of P4, then they are likely inconsequential to overall
energy balance due to the limited amount of time during which peak concentrations are present. It
is possible that the elevation of ovarian sex hormones in previous work was a result of both an
intensity and duration effect, as per the design of their exercise protocols, whereby exercise of
light intensity was immediately followed by that of moderate and vigorous intensity until physical
exhaustion (Bonen et al. 1991; Bonen et al. 1979; Jurkowski et al. 1978; Redman et al. 2003). As
such, the lack of response in P4 to VICT may have been a reflection of the shorter duration of
exercise implemented in the current project.

Additionally, the use of VICT precludes

generalization of our findings to exercise of lesser intensities (i.e., moderate-intensity continuous
training, or MICT), or to that of intermittent-style training, such as high-intensity interval training
(HIIT) or sprint interval training (SIT). Further research is necessary to elucidate the appetiteregulatory response in the LP following various exercise protocols, and work regarding this topic
is currently undergoing in our laboratory.
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Second, as per the relatively small sample size in the current project and calculations of
observed power, caution should be taken when interpreting the results as it is possible that a Type
II error may have occurred in instances where no differences were detectable. For example, though
there was no main effect of phase (P=0.973) or time (P=0.305) for changes in PYY3-36 relative to
baseline, the observed power for each main effect equaled to 0.07 and 0.282, respectively,
suggesting there is a large chance (~72-98%) that we failed to detect an effect that was present.
Based on our observed effect size of f=0.18 in regard to the main effect of phase, a sample size of
86 participants would have been required to detect a difference in PYY3-36 between phases with
80% power. As the sample size of the current project (n = 8 for hormonal data) was well below
this threshold, we are unable to conclude with a high level of certainty that the observed effect was
representative of what would occur in the actual population. Similarly, to detect a difference in
changes in PYY3-36 over time relative to baseline with 80% power and based on the observed effect
size (f=0.41) for the main effect of time, 18 participants would be needed. Thus, while we have
concluded that menstrual cycle phase and exercise appear to have no effect on PYY3-36 levels, this
conclusion should be interpreted in the context of our statistical results. As per acylated ghrelin,
the observed power for the main effect of phase and time equaled to 0.652 and 0.879, respectively,
and that of the main effect of time for active GLP-1 equaled to 0.733, suggesting greater confidence
can be placed that the effects observed in these hormones are what we would expect to occur in
the actual population. In regard to the sex hormones, the observed power for the main effect of
phase and time for E2 was 0.44 and 0.71, respectively, and for that of the main effect of phase for
P4 equaled to 0.77. Nevertheless, while it is important to consider the findings of the current
project in the context of our statistical results, the importance of the observed effects should not
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be discounted, as they provide a starting point for understanding the effects of appetite regulation
in the LP.
In addition, while it appears that sex hormones may play a role in the orexigenic response
to exercise, the mechanisms involved in this effect remain to be elucidated. As aforementioned,
E2 may be directly involved in the regulation of ghrelin expression, as evidenced by an increase in
ghrelin mRNA and plasma ghrelin concentrations following ovariectomy in rats that was reversed
when normal levels of E2 were restored (Matsubara et al. 2004). In addition, the role of E2 in fat
metabolism may influence ghrelin expression, as E2 is known to promote lipolysis, thus increasing
plasma free fatty acid concentrations and utilization of fat as substrate (Buffenstein et al. 1995). It
is possible that this increase in fat utilization reduces the available O-octanoyl in circulation – the
eight-carbon fatty acid required for acylation of ghrelin and thus, activation of its orexigenic
effects. As such, due to its role in fat metabolism, an increased amount of E2 in the FP may be
indirectly associated with a decrease in plasma acylated ghrelin, and thus a concomitant reduction
in perceptions of hunger post-exercise.
Only three previous studies have examined the effect of menstrual phase on appetite
regulatory hormones (Brennan et al. 2009; Campolier et al. 2016; McKie et al. 2018), with two
evaluating only anorexigenic hormones (Brennan et al. 2009; Campolier et al. 2016) and none
evaluating the relationship between these hormones post-exercise. Based on this work, fasted/preexercise differences in acylated ghrelin or GLP-1 concentrations between phases were not
expected. Campolier et al. (2016) observed lower fasted total PYY in the LP compared to the
early FP, though the current investigation demonstrated no significant differences in PYY between
phases at baseline. However, it is important to note that we examined PYY3-36 making it difficult
to establish direct comparisons between other observations of total PYY. In the absence of
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exercise or a test meal, the normal patterns of appetite hormone release are expected (see Chapter
1), as there is no evidence to suggest there are sex differences in the physiological mechanisms
underlying short-term regulation of appetite (i.e. signaling mechanisms of gut peptides to the
arcuate nucleus, the central integration of these signals, and the release of hypothalamic
neuropeptides to modulate perceptions of hunger and satiety). Rather, existing evidence suggests
potential differences between males and females is manifested in the appetite hormone responses
to exercise, as outlined in Chapter 2, and that these differences may play a role in the difficulties
females experience with weight loss from exercise.
Alternatively, such difficulties may not be related to the homeostatic response to exercise,
and instead may be related to digestive responses across the menstrual cycle, as evidenced by the
differential post-prandial responses across phases observed in the limited work examining appetite
hormone response between phases. Brennan at al. (2009) observed delayed gastric emptying and
lower total GLP-1 concentrations in the FP compared to the LP following ingestion of an oral
glucose load, though a post-prandial difference between phases has not been reproduced in the
other work available (McKie et al. 2018). Furthermore, in agreement with previous work (Brennan
et al. 2009), Campolier and colleagues (2016) demonstrated slower gastric emptying in the FP
compared to the LP, suggesting sex hormones may influence this digestive process, though total
PYY was not directly associated with sex hormone concentrations. Similarly, we observed no
correlations between PYY3-36 and sex hormones in the current study, again suggesting that sex
hormones do not influence the anorexigenic appetite regulatory response to acute exercise in
females. Further work is necessary to explore these preliminary findings.
Although a greater energy intake in the LP was expected due to the well-documented
changes that occur in this variable across the menstrual cycle, the current investigation did not find
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significant differences in total energy intake across 48 h between the FP and LP, excluding the day
prior to each experimental session as this day was intentionally standardized between phases. This
observation may be due to the fact that we utilized self-reported dietary logs as is a common
strategy due to its feasibility, though is associated with greater variability between participants
compared to standardized measures of energy intake (Jeacocke et al. 2010). In addition, energy
intake is often underreported by ~25-50% using self-reported methods (Hise et al. 2002),
and it is possible that the limitations associated with this method underlies our finding.
Alternatively, a more apparent difference may have been found had we measured energy intake
across each phase during a control period when no exercise was performed. Inclusion of this
measurement may have provided a clearer picture of any effects of exercise on energy intake rather
than to a standardized day across phases, and would have allowed for a direct examination of
energy intake between phases in the absence of exercise. Future work should consider this
distinction, and include a replicated crossover design with a control session to allow for a more
thorough comparison of energy intake between phases.
Lastly, it should be noted that the hormones assessed in the current study do not provide a
complete understanding of appetite regulation in humans, as the effects of peripheral appetite
hormones are ultimately mediated by changes in hypothalamic neuropeptides discussed in Chapter
1. The majority of work examining these neuropeptides has been performed in animal models,
and extension of this work in human models is a necessary step to understanding appetite
regulation. Even further, this step is particularly important to understanding appetite-regulation
across the menstrual cycle, as the rodent menstrual cycle is not an appropriate representation of
that in women (Asarian et al. 2013).
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Future Directions
As the first group to examine the appetite-regulatory response to acute exercise in the LP
of the menstrual cycle, there are a number of avenues for further research that should be
considered. First and foremost, as with any novel scientific finding, the reproducibility of our
results should be examined, requiring replication of the current experimental design. Relatedly,
in light of recent research demonstrating that true interindividual variability exists in the hormonal
and subjective appetitive-response to acute exercise beyond that which would be expected due to
measurement error and random variability (Goltz et al. 2018), future directions should focus on
the assessment of interindividual differences in females using a replicated crossover design. A
comparison of sex-based differences in interindividual variability may allow for a unique
examination of whether females are more or less likely to compensate for an exercise-induced
energy deficit compared to males, which may contribute to the weight loss difficulties females
experience with exercise.

Furthermore, importance should be placed on elucidating the

independent roles of E2 and P4 on the neural control of feeding behaviours. Methodologically, it
is not possible to isolate the effects of P4 in naturally cycling women, as it is always present with
increasing levels of E2, however P4 treatment in males may offer a unique avenue for distinguishing
the independent effect of P4 fluctuations on energy intake. Given the participant characteristics
of the current project, examining exercise-induced changes in appetite hormones and appetite
perceptions across the menstrual cycle in hormonal birth control users, post-menopausal women,
overweight/obese and sedentary populations is needed. Lastly, future work should extend these
findings to examine appetite responses in the LP following chronic exercise, as long-term energy
balance ultimately dictates weight loss/gain. Overall, these questions will lead to an improved
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understanding of the relationship between exercise and appetite control in women, providing more
effective strategies for weight management.
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Appendix A

CONSENT TO PARTICIPATE IN RESEARCH
LETTER OF INFORMATION

Date:

Title of Study: Examining the potential involvement of sex hormones on appetite regulation
(REB #5856)
Dear ______________________________:
You are being invited to participate in a research study conducted by Tom J. Hazell (PhD) and
Sara Moniz (BA Kin) from the Energy Metabolism Research Laboratory. In order to participate
it is important you are: a) between 18-30 years old, b) recreationally active <3/wk, c) healthy, d)
normally menstruating, e) not currently pregnant, do not have plans to become pregnant during
the duration of the study, and have not been pregnant (>3 months) within the last 3 years, and e)
not using birth control or using no form of hormonal contraceptive as this project is designed to
determine how sex hormones influence appetite hormones.
PURPOSE OF THE STUDY
The primary purpose of this study is to examine the effects of vigorous-intensity continuous
running on concentrations of sex hormones and examine their associations with post-exercise
alterations in appetite-regulating hormones in women during the follicular phase (FP) and luteal
phase (LP) of the menstrual cycle.
PROCEDURES
This study requires you to visit the Energy Metabolism Research Laboratory 3 separate times,
one for a familiarization session (~1 h 15 min) and then for 2 testing sessions (~4 h, one session
in both the FP and LP) for a total time commitment of ~9 hours. The FP constitutes days ~1-11
of the menstrual cycle, including time of menses, and is the period of the cycle where levels of
female sex hormones (estradiol and progesterone) are at the lowest concentration. The LP
constitutes days ~16-28 of the menstrual cycle and is the period of time following ovulation
(days ~12-15) where levels of estradiol and progesterone are increased relative to the FP.
Menstrual phase will be subject-monitored through oral body temperature taken daily upon
awakening, as well as through the use of at-home ovulation kits. Participants will be provided
with an ovulation kit, instructed on its use, and will report the status of the test as well as body
temperature each morning to the researcher via text or email. The familiarization session will
include a test of cardiorespiratory fitness (𝑉̇ O2max test), consisting of a graded running test
performed until exhaustion. Following a 5 min warm up, you will begin the test running at a
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speed between 5-7 mph at 0% incline. Every 2 minutes thereafter, incline on the treadmill will
increase by 2%. The test will continue until volitional fatigue. All experimental sessions
(separated by 1 week minimum) will include a standardized breakfast (consisting of a chocolate
chip Clif bar) and 40 min exercise session (5 min warm-up, 30 min continuous running, and 5
min cool-down) followed by 2 hours post-exercise where participants rest comfortably and
quietly in the laboratory (i.e. reading. A measurement of resting gas exchange will occur for 15
minutes before the exercise session, 30 minutes post-exercise, and for the final 15 minutes of the
remaining 2 hours post-exercise. This measurement involves wearing a sanitized mask that is
connected to a metabolic cart. Blood samples will also be drawn from the forearm pre- and postexercise (two 3 mL samples per draw, 4 total blood draws). Blood draws will be taken from the
inner elbow while lying supine by a trained researcher. All equipment will be sterile one-time
use. Blood draw site will be cleaned prior to each sample and researcher will wear clean gloves
to ensure cleanliness. You will also be asked several questions before and after exercise to
determine your feelings of hunger and satiety as well as record dietary intake the day before the
trial, on trial day and the day after. You will also be required to give a detailed history of your
menstrual cycle, including the length of recent cycles, when you began menstruating, and if you
have ever had any irregular menstrual cycles.
POTENTIAL RISKS AND DISCOMFORTS
We appreciate that this study requires you to discuss highly personal and sensitive information
and we will do our best to make you as comfortable as possible; should you feel uncomfortable
at any point you are free to withdraw from the study. All information regarding the menstrual
cycle is only used to ensure that our testing days are done at the appropriate times.
Should this information be required for any presentations and/or publications, you will not
identifiable by the information provided and results will be presented in group form. There is a
possibility of mild muscle soreness and/or fatigue typical of an exercise session. You may feel
some discomfort (lightheadedness, nausea, sore muscles) due to the intensity of the training or
𝑉̇ O2max test typical of strenuous physical exertion. Close monitoring of participants throughout
the duration of the 𝑉̇ O2max test will limit this risk to ensure the test proceeds in a safe manner and
will be immediately terminated should you display any signs of distress or upon your request.
Risk of falling during the test will be limited as two researchers will always be present during
testing. Although phlebotomy is safe when done by certified and trained individuals there is a
small risk of bruising at the puncture site which can be reduced by keeping pressure on the site
for several minutes after the needle is withdrawn. In some rare cases the vein may become
inflamed after the sample is withdrawn however using a warm compress can alleviate this. There
is a small risk of infection any time the skin is broken however this rarely occurs when
equipment is properly sterilized and disposed of. Some people may also experience lightheadedness if they are uncomfortable with needles and if this occurs the experiment will be
terminated immediately. The risk of falling and/or fainting is minimum as the participant will be
lying supine.
POTENTIAL BENEFITS TO SUBJECTS AND/OR SOCIETY
The potential benefits of your participation include a better understanding of your
cardiorespiratory fitness based on the results of a 𝑉̇ O2max test, an assessment which typically
costs ~$120 when performed at commercial facilities. Results from this study will further our
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understanding of appetite regulation in females and may offer new insights into potential
mechanisms involved in appetite regulation. Thus, participants will gain insight into how natural
hormonal changes may affect their weight loss efforts and their eating habits which may lead to
improved weight loss strategies for women.
CONFIDENTIALITY
All information obtained in connection with this study will be de-identified. It is possible that
data related to your participation (i.e., your 𝑉̇ O2max max value, hormone levels, appetite
scores, energy intake data) and basic demographic data such as physical activity level,
height, weight, and age) will be submitted to an ‘open access’ database upon publication.
This data will be completely anonymized and de-identified by removing names and any
other information that could possibly identify any participant. All contact information is
collected and stored on a master list in a password-protected file with access to only the study
investigators. All participants will be assigned an arbitrary number to ensure anonymity. This
study number will be used in all data collection files and mean data will be stored in a password
protected file for comparison with future studies. All results will be collapsed before analysis.
All blood samples will be stored in secured location until analysis and subsequently destroyed
after a period of 5 years. All other data will also be retained and destroyed after 5 years.
PARTICIPATION AND WITHDRAWAL
Your participation in this research study is completely voluntary. If you are a student and
volunteer to be in this study, you may withdraw at any time without any effect on your status at
Wilfrid Laurier University. If you are not a student, you may withdraw at any time. You may
also refuse to answer any questions you feel are inappropriate and still remain in the study. The
investigators may withdraw you from this research if circumstances arise which warrant doing so
(i.e. lack of effort during exercise sessions, difficulty scheduling, repeatedly missing scheduled
sessions, etc.). Please note that should you withdraw from the study all personal information and
blood samples will be immediately destroyed.
FEEDBACK OF THE RESULTS OF THIS STUDY
If you would like a copy of a lay summary of the results, please check the box below and include
the preferred address for communication (i.e. email or mailing address). The results from this
study will be reported in general terms in the form of speech or writing that may be represented
in manuscripts submitted for publication in scientific journals, or oral and/or poster presentations
at scientific meetings, seminars, and/or conferences. We plan to publish this study in an
academic journal. The information published in a journal or subsequent studies will not identify
you in any way. Copies will be available upon request.

SUBSEQUENT USE OF DATA
This de-identified data may be used in subsequent studies (with no link to your personal
information). You will receive a copy of the consent form after it has been signed and do not
waive any legal rights by signing it.
------------------------------------------------------------------------------------------------------------
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This letter is yours to keep. If you have any questions, feel free to call: Dr. Tom Hazell 519884-1970 x3048
Further, if you have any questions about the conduct of this study or your rights as a research
subject you may contact Dr. Jayne Kalmar, Research Ethics Board (REB) Chair
(REBchair@wlu.ca / 519-884-0710 x 3131). This project has been reviewed and approved by
the REB – Approval #5856.
Sincerely,
Sara C. Moniz (moni8339@mylaurier.ca), MKin Student, and Dr. Tom Hazell (thazell@wlu.ca),
Associate Professor
Department of Kinesiology and Physical Education, Wilfrid Laurier University, Waterloo, ON
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Title of Study: Examining the potential involvement of sex hormones on appetite regulation
(REB #5856)
Consent Statement
Principal Investigators: Dr. Tom Hazell, Sara C. Moniz
I have read the accompanying “Letter of Information” and have had the nature of the study and
procedures to be used explained to me. All of my questions have been answered to my
satisfaction.
By signing below, I agree to participate in this study

NAME (please print):
SIGNATURE:
DATE:

______________________________________

______________________________________

______________________________________

NAME OF PERSON OBTAINING INFORMED CONSENT (please print):
______________________________________

SIGNATURE OF PERSON OBTAINING INFORMED CONSENT:
______________________________________

DATE:

______________________________________
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Appendix E
Daily Food Log

Instructions:

1. Record all food intake for a 3-day period (day before session, day of session, day
after session)
2. Try to consume foods that you would typically eat as part of your regular diet.
3. Keep your recording sheets with you at all times. (Snacks are typically consumed
unpredictably and, as a result, it is impossible to record them accurately unless
your recording forms are nearby.)
4. Use a small food scale if you have one or standard-measuring devices
(measuring cups, measuring spoons, etc.) to record the quantities consumed, as
accurately as possible. If you do not eat all of the item re-measure what’s left and
record the difference.
5. Record combination foods separately (i.e., hot dog, bun, and condiments) and
include brand names of food items (list contents of homemade items) whenever
possible.
6. For packaged items, use labels to determine quantities.

Example:

Time of Day
(i.e. 8:15 am,
12:30 pm)

Food Item (include
brand name if possible)

Quantity

Notes

(i.e. g, mL,
cups, etc.)

(i.e. ingredients & amounts
used if possible)

9:30 am

Eggs

2 whole

½ tsp salt, ½ cup cheese,
½ tsp butter

9:30 am

Egg whites

½ cup

-

10:15 am

Tropicana orange juice

1 cup

-

11:05 am

Apple

1 whole

-

1:50 pm

Domino’s Pizza

4 slices

Pepperoni, mushroom,
cheese

1:50 pm

Pepsi

500 ml

-
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DAY 1 (day before session)

Date: ___________

Time of Day

Food Item

Quantity

Notes

(i.e. 8:15 am,
12:30 pm)

(Include brand name if
possible)

(i.e. g, mL,
cups, etc.)

(i.e. ingredients & amounts
used if possible)
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Table 1. Individual participant characteristics
Height
Weight
GLTE-Q Activity
𝑽̇O2max
Participant
BMI
(cm)
(kg)
Score
Levels
(mL∙kg-1∙min-1)
1
167.0
88.9
31.9
37.08
58
Active
2
165.0
57.6
21.2
38.10
27
Active
3
166.0
71.5
25.9
29.10
31
Active
4
163.4
52.5
19.7
41.40
18
Mod A
5
155.0
55.0
22.9
44.20
28
Active
6
163.2
59.1
22.2
35.30
37
Active
7
162.1
54.0
20.5
37.90
45
Active
8
162.0
64.2
24.5
39.80
38
Active
9
157.2
52.6
21.3
37.10
47
Active
10
166.0
64.2
23.3
37.10
35
Active
11
170.4
61.8
21.3
30.10
42
Active
MEAN
163.39
61.95
23.34
37.02
37
±SD
±4.37
±10.69
±3.75
±4.40
±12
Note: Activity levels are based on the Godin-Leisure Time Exercise Questionnaire scoring
index and interpretation, where a score: <14 = insufficiently active/sedentary; 14-23 =
moderately active; >24 = active.

